Tinnitus

H8_TINNITUS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H93.1 Hospital discharge: ICD-9 — 3883 Cause of death: ICD-10 — H93.1 Cause of death: ICD-9 — 3883 2 out of 7 registries used, show all original rules.	10342
4. Check minimum number of events None	10342
5. Include endpoints None	10342
6. Filter based on genotype QC (FinnGen only)	10342

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H93
Name in latin: Tinnitus (auris/aurium)

NAME	H8_TINNITUS
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H931
HD_ICD_9	3883
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H931
COD_ICD_9	3883
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Tinnitus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	61296	32184	28857
Only index persons	59727	31616	28111
Unadjusted period prevalence (%)
Whole population	0.86	0.92	0.81
Only index persons	1.12	1.16	1.07
Median age at first event (years)
Whole population	55.32	56.73	53.86
Only index persons	55.25	56.63	53.71

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10342	5978	4364
Unadjusted period prevalence (%)	1.99	2.04	1.92
Median age at first event (years)	57.07	56.35	58.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9262: Matched controls
92621

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z01.1

ICD-10 Finland

Examination of ears and hearing

11.6

323.0

2883

3464

UDC00

NOMESCO Finland

Ear microscopy

8.2

323.0

1283

1788

DFF00

NOMESCO Finland

Pure tone audiometry

25.6

323.0

2397

1244

N07CA01

ATC

betahistine; oral

11.6

323.0

1999

2140

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

124.0

323.0

2981

353

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

37.6

323.0

427

119

DFF15

NOMESCO Finland

Speech audiometry

15.7

323.0

572

387

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

51.9

323.0

441

H93.1

ICD-10 Finland

Tinnitus

16384.0

323.0

9217

819

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

160.8

323.0

914

SPAT1043

SPAT

Audiometry

5.2

323.0

1339

2906

H02

ICPC

Hearing complaint

5.3

323.0

1574

3460

H03

ICPC

Tinnitus, ringing/buzzing ear

16.7

323.0

680

437

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

79.6

297.1

337

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

13.2

296.9

539

430

DAX08

NOMESCO Finland

Fitting of hearing aid

20.8

244.5

371

185

Z97.4

ICD-10 Finland

Presence of external hearing-aid

15.7

229.3

386

256

H91.9

ICD-10 Finland

Hearing loss, unspecified

8.9

214.1

478

565

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

43.0

210.6

264

H29

ICPC

Ear symptom/complaint other

3.2

201.2

1202

4151

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

62.2

181.5

213

R42

ICD-10 Finland

Dizziness and giddiness

2.2

180.1

2181

11228

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

169.6

174.3

183

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

12.4

159.7

297

247

H81.0

ICD-10 Finland

Ménière disease

8.0

156.2

369

476

R01AD09

ATC

mometasone; nasal

1.8

150.3

4157

28896

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

14.7

140.5

242

169

H91.1

ICD-10 Finland

Presbycusis

6.3

139.0

390

644

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

336.9

132.9

134

G44.2

ICD-10 Finland

Tension-type headache

2.3

124.0

1328

6323

H93.2

ICD-10 Finland

Other abnormal auditory perceptions

18.1

123.0

195

110

A02BC05

ATC

esomeprazole; systemic

1.7

116.5

3767

26744

A02BC02

ATC

pantoprazole; systemic

1.7

115.5

5888

47390

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

113.1

3679

26097

R51.80

ICD-10 Finland

Headache

2.1

110.9

1370

6934

M03BX02

ATC

tizanidine; oral

1.6

108.4

5620

45016

L01

ICPC

Neck symptom/complaint

2.1

105.6

1319

6695

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

79.8

104.4

118

R01AD08

ATC

fluticasone; nasal

1.7

103.4

2576

16781

R5120

NOMESCO Finland

Preparation of an aid

6.8

93.2

245

370

N06AX11

ATC

mirtazapine; oral

1.7

91.8

2825

19418

H83.3

ICD-10 Finland

Noise effects on inner ear

11.4

91.1

175

156

H92.0

ICD-10 Finland

Otalgia

3.4

89.3

461

1400

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

89.2

2159

13826

M25.5

ICD-10 Finland

Pain in joint

1.7

88.4

2521

16926

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.3

87.2

928

4358

A02BC03

ATC

lansoprazole; oral

1.7

87.0

2609

17751

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

86.9

3022

21389

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.1

85.3

243

409

M79.6

ICD-10 Finland

Pain in limb

1.6

84.2

3110

22308

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

80.1

762

3381

M01AH05

ATC

etoricoxib; oral

1.5

80.1

5212

42505

N03AX16

ATC

pregabalin; oral

1.7

79.8

2122

13893

R01AD12

ATC

fluticasone furoate; nasal

1.6

79.5

2518

17293

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

78.3

2355

15943

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

76.7

1000

5118

H13

ICPC

Plugged feeling ear

1.8

76.6

1460

8607

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

76.6

1059

5550

R4135

NOMESCO Finland

Rehabilitation for hearing problems

27.3

72.2

100

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.2

72.2

815

3913

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

70.8

726

3335

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.2

70.5

770

3641

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

70.2

6022

51368

M79.1

ICD-10 Finland

Myalgia

1.9

69.9

1109

6117

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

68.6

2011

13441

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

68.1

1750

11273

R03AC02

ATC

salbutamol; inhalant

1.5

67.9

4419

35474

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

67.8

2453

17287

J01FA10

ATC

azithromycin; systemic

1.5

67.5

4926

40458

M54.5

ICD-10 Finland

Low back pain

1.5

67.0

2732

19797

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

66.4

2028

13681

N02BE01

ATC

paracetamol; systemic, rectal

1.6

66.0

7617

68855

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

66.0

1838

12095

H81

ICPC

Excessive ear wax

1.8

65.8

1292

7658

DC1AD

NOMESCO Finland

Temporalbone CT

10.4

65.8

132

129

A98

ICPC

Health maint/preventive medicine

2.2

65.7

8812

83397

J01CA04

ATC

amoxicillin; systemic

1.5

65.0

6971

61767

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

64.1

1488

9286

K07.60

ICD-10 Finland

Snapping jaw

2.7

62.7

463

1784

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

62.6

2038

13941

M01AB05

ATC

diclofenac; systemic, rectal

1.5

62.6

5818

49775

H02AB06

ATC

prednisolone; systemic

1.5

62.5

3894

30783

C07AA05

ATC

propranolol; systemic

1.7

60.8

1625

10544

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

60.3

1682

11034

M01AE02

ATC

naproxen; oral, rectal

1.4

59.5

4800

39756

N03AX12

ATC

gabapentin; oral

1.7

59.3

1347

8333

J01AA02

ATC

doxycycline; systemic

1.5

58.8

6824

60591

3883A

ICD-9 Finland

Other disorders of ear, Tinnitus

+∞

58.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

58.2

1739

11607

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.9

58.2

876

4721

L08

ICPC

Shoulder symptom/complaint

1.6

58.1

1600

10445

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.3

57.9

308

956

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

57.8

5349

45348

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.3

57.7

574

2591

A02BC01

ATC

omeprazole; systemic

1.5

56.5

2296

16489

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

56.5

872

4740

J02AC01

ATC

fluconazole; systemic

1.4

55.1

3288

25564

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

55.1

840

4543

H01

ICPC

Ear pain/earache

1.9

54.9

828

4458

M02AA07

ATC

piroxicam; topical

1.5

54.6

3055

23440

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

54.2

3987

32222

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

54.2

1043

6112

N17

ICPC

Vertigo/dizziness

1.9

54.0

903

5047

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

53.7

801

4293

DFF59

NOMESCO Finland

Other assessment of balance

7.4

53.5

131

180

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

53.0

4624

38488

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

52.7

565

2639

L03

ICPC

Low back symptom/complaint

1.5

52.6

1940

13590

K30

ICD-10 Finland

Functional dyspepsia

1.9

52.2

897

5060

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

52.2

2371

17392

A02BA02

ATC

ranitidine; systemic

1.6

52.1

1628

10953

UJF32

NOMESCO Finland

Coloscopy

1.5

52.0

2133

15301

D33.30

ICD-10 Finland

Acoustic neuroma

14.2

51.8

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

51.8

913

5193

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

51.5

856

4767

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

51.3

3830

30929

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

50.4

706

3695

H80.9

ICD-10 Finland

Otosclerosis, unspecified

9.6

49.6

103

108

AA1AD

NOMESCO Finland

CT of head and brain

1.5

49.3

1860

13066

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

49.3

586

2865

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

48.7

561

2704

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

48.7

2595

19613

R06AX27

ATC

desloratadine; oral

1.5

48.3

2122

15409

N06AX21

ATC

duloxetine; oral

1.8

47.8

909

5295

R21

ICPC

Throat symptom/complaint

1.6

47.8

1447

9634

M54.2

ICD-10 Finland

Cervicalgia

2.1

47.5

604

3036

SPAT1041

SPAT

Comprehensive hearing test

6.5

47.4

126

195

J01DB01

ATC

cefalexin; oral

1.4

47.3

7026

63595

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

47.1

3274

25972

L17

ICPC

Foot/toe symptom/complaint

1.5

46.9

2033

14709

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

46.5

3660

29657

R06AE07

ATC

cetirizine; oral

1.4

46.4

3521

28342

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

46.3

1312

8578

M01AC06

ATC

meloxicam; systemic, rectal

1.4

45.9

3065

24109

TDA90

NOMESCO Finland

Removal wax from ear

6.6

45.8

121

186

K80

ICPC

Cardiac arrhythmia NOS

2.0

45.7

635

3309

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

45.7

1329

8748

H81.3

ICD-10 Finland

Other peripheral vertigo

3.1

45.4

263

868

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

45.4

4129

34236

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

45.4

3063

24126

C05AA08

ATC

fluocortolone; rectal, topical

1.6

45.2

1197

7681

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

45.2

2300

17176

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

44.8

4318

36122

N03AE01

ATC

clonazepam; systemic

2.1

44.4

524

2553

N05CF01

ATC

zopiclone; oral

1.4

43.9

2589

19864

N06AB10

ATC

escitalopram; oral

1.5

43.9

1547

10663

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

43.7

4699

39940

KMAK

NOMESCO Finland

1.4

43.7

4208

35138

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

43.7

474

2225

Z01.2

ICD-10 Finland

Dental examination

1.4

43.5

3294

26420

N01

ICPC

Headache

1.9

43.3

719

3994

R52.9

ICD-10 Finland

Pain, unspecified

1.9

43.3

694

3808

R01AD01

ATC

beclometasone; nasal

1.6

42.7

1228

8049

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

42.6

3801

31299

R53

ICD-10 Finland

Malaise and fatigue

1.5

42.2

1527

10578

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

41.8

868

5189

N05BA04

ATC

oxazepam; oral

1.5

41.6

1957

14342

E0000UV

ATC

1.4

41.5

3112

24861

R00.2

ICD-10 Finland

Palpitations

2.0

41.2

587

3085

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

41.1

1368

9291

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

40.4

3014

24030

G47.3

ICD-10 Finland

Sleep apnoea

1.5

40.3

1701

12175

XA410

NOMESCO Finland

BAEP

140.6

39.7

N06AX16

ATC

venlafaxine; oral

1.6

39.6

1083

6998

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

38.6

R06.0

ICD-10 Finland

Dyspnoea

1.4

38.5

1890

13935

N02AX02

ATC

tramadol; systemic, rectal

1.3

38.4

3431

28108

R13

ICD-10 Finland

Dysphagia

2.0

38.3

519

2675

H61.2

ICD-10 Finland

Impacted cerumen

2.1

38.2

444

2147

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

37.9

500

2549

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

23.6

37.8

WX110

NOMESCO Finland

Local anesthesy

1.3

37.8

5715

50654

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

37.7

2178

16552

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

37.7

3250

26449

A02BC04

ATC

rabeprazole; oral

1.8

37.3

695

4011

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

36.9

266

1012

H84

ICPC

Presbyacusis

3.4

36.8

187

563

R06.5

ICD-10 Finland

Mouth breathing

1.8

36.4

698

4063

N06AA09

ATC

amitriptyline; systemic

1.7

36.2

826

5067

N05CF02

ATC

zolpidem; oral

1.5

36.1

1422

10001

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

36.1

949

6056

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

6.7

35.9

140

R74

ICPC

Upper respiratory infection acute

1.4

35.8

2044

15478

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.4

35.7

315

1338

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

35.5

816

5014

R51

ICD-10 Finland

Headache

2.1

35.3

397

1894

G04CA01

ATC

alfuzosin; oral

1.7

35.3

828

5121

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

35.2

584

3241

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

35.2

297

1234

G04CA02

ATC

tamsulosin; oral

1.5

35.1

1493

10671

F29

ICPC

Eye symptom/complaint other

1.8

35.0

634

3623

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

35.0

785

4791

J01FA09

ATC

clarithromycin; systemic

1.4

35.0

2513

19795

L13

ICPC

Hip symptom/complaint

1.5

34.9

1221

8362

R05

ICD-10 Finland

Cough

1.5

34.8

1493

10685

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

9.5

34.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

34.7

3430

28399

A11

ICPC

Chest pain NOS

1.8

34.6

608

3442

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

34.4

511

2723

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

34.4

1214

8325

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

34.3

2902

23449

N06AB04

ATC

citalopram; systemic

1.4

34.3

1685

12392

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

34.2

541

2950

J34.2

ICD-10 Finland

Deviated nasal septum

2.1

34.1

425

2117

L12

ICPC

Hand/finger symptom/complaint

1.6

34.0

1079

7215

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.6

33.6

257

1011

L04

ICPC

Chest symptom/complaint

2.0

33.5

463

2404

S18

ICPC

Laceration/cut

1.3

33.4

3354

27790

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

33.2

1190

8187

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

33.1

442

2263

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

33.1

1455

10456

M01AX05

ATC

glucosamine; oral

1.4

32.7

1568

11462

D06

ICPC

Abdominal pain localized other

1.8

32.5

606

3494

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

32.3

3009

24612

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

32.3

437

2247

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

32.3

618

3594

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

32.0

929

6074

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

31.9

2145

16661

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

31.7

2094

16214

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

31.7

1929

14728

R05

ICPC

Cough

1.4

31.6

1676

12480

L02

ICPC

Back symptom/complaint

1.7

31.3

675

4070

R07.3

ICD-10 Finland

Other chest pain

1.7

31.3

713

4369

S29

ICPC

Skin symptom/complaint other

1.5

31.1

1268

8957

M01AX17

ATC

nimesulide; oral

1.4

30.9

1959

15055

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

30.8

608

3569

U02

ICPC

Urinary frequency/urgency

1.6

30.7

980

6552

DE2BM

NOMESCO Finland

Acoustic channel MRI examination with 3 Tesla magnet

110.4

30.7

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

30.6

265

1116

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

30.5

3425

28721

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

30.3

1224

8627

D07AC01

ATC

betamethasone; topical

1.3

30.1

2653

21474

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

30.0

1115

7723

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

30.0

7837

73838

H91.8

ICD-10 Finland

Other specified hearing loss

6.7

29.9

116

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

29.3

498

2783

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

29.3

1870

14364

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

29.2

747

4721

K04

ICPC

Palpitations/awareness of heart

2.0

29.2

398

2053

C07AB07

ATC

bisoprolol; oral

1.3

29.2

3650

30998

J01DA01

ATC

[U] cefalexin; systemic

1.3

29.1

5076

45025

R07.0

ICD-10 Finland

Pain in throat

1.9

29.0

442

2378

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

29.0

629

3797

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

28.8

909

6056

R12

ICD-10 Finland

Heartburn

1.8

28.8

534

3072

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

28.6

1278

9189

H02AB04

ATC

methylprednisolone; systemic

1.5

28.6

1104

7704

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

28.5

1469

10857

J01FA06

ATC

roxithromycin; oral

1.3

28.2

3178

26578

R52.2

ICD-10 Finland

Other chronic pain

2.3

28.1

276

1237

L15

ICPC

Knee symptom/complaint

1.4

28.0

1566

11745

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

27.8

902

6046

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

27.8

466

2591

XF402

NOMESCO Finland

ECG with work load test

1.6

27.8

869

5779

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

27.7

330

1612

S82

ICPC

Naevus/mole

1.5

27.7

893

5982

D01

ICPC

Abdominal pain/cramps general

1.6

27.5

763

4925

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

27.4

637

3921

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

27.2

288

1337

K08.80

ICD-10 Finland

Toothache NOS

1.7

27.2

585

3523

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

27.1

G50.1

ICD-10 Finland

Atypical facial pain

3.0

27.1

164

562

H91

ICD-10 Finland

Other hearing loss

6.0

27.0

125

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

27.0

1286

9353

S21

ICPC

Skin texture symptom/complaint

1.5

26.8

928

6313

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

26.7

1312

9604

ZXA10

NOMESCO Finland

Bilateral

1.4

26.6

1372

10126

M01AH02

ATC

rofecoxib; oral

1.5

26.6

1011

7021

H66.9

ICD-10 Finland

Otitis media, unspecified

2.0

26.6

352

1796

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

26.5

841

5608

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

26.5

679

4294

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

26.4

300

1438

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.7

26.3

619

3823

P06

ICPC

Sleep disturbance

1.6

26.2

709

4545

SPAT1153

SPAT

Removal of sutures

1.3

26.2

2468

20081

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

26.2

452

2541

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

25.9

492

2852

UKC02

NOMESCO Finland

Cystoscopy

1.5

25.9

1121

7998

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

25.9

444

2490

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

25.7

2470

20140

R01AD11

ATC

triamcinolone; nasal

1.6

25.7

673

4277

M54

ICD-10 Finland

Dorsalgia

1.6

25.6

794

5263

ZXA05

NOMESCO Finland

Left side

1.3

25.3

1925

15157

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.8

25.3

109

289

A03FA02

ATC

cisapride; oral, rectal

1.7

25.3

582

3570

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

25.3

543

3268

J01MA02

ATC

ciprofloxacin; systemic

1.3

25.2

2931

24516

Z71.8

ICD-10 Finland

Other specified counselling

1.4

25.1

1744

13538

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

3.8

25.1

108

287

A06AC51

ATC

ispaghula, combinations; systemic

1.9

25.0

385

2078

K02.1

ICD-10 Finland

Caries of dentine

1.3

24.8

4442

39166

R06AE09

ATC

levocetirizine; oral

1.5

24.8

1044

7403

XKD00

NOMESCO Finland

Uroflowmetry

1.5

24.8

1067

7602

M02AA10

ATC

ketoprofen; topical

1.4

24.6

1187

8644

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

24.5

792

5299

R35

ICD-10 Finland

Polyuria

1.8

24.4

446

2551

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

24.2

2124

17071

A04

ICPC

Weakness/tiredness general

1.5

24.1

862

5900

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

24.1

1722

13411

H28

ICPC

Limited function/disability (H)

5.2

24.0

145

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

24.0

384

2104

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

23.9

694

4528

WX002

NOMESCO Finland

Sedation and analgesia

1.4

23.8

1499

11436

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

23.8

539

3292

N06AX26

ATC

vortioxetine; oral

1.8

23.8

388

2140

R06AX22

ATC

ebastine; oral

1.4

23.6

1266

9394

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

23.5

423

2408

-1

NOMESCO Finland

1.3

23.4

2440

20066

D02

ICPC

Abdominal pain epigastric

1.8

23.4

413

2336

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

33.4

23.3

I49.1

ICD-10 Finland

Atrial premature depolarization

2.1

23.3

263

1261

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

23.1

378

2086

ZXA00

NOMESCO Finland

Right side

1.3

23.0

2039

16386

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

6.5

23.0

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

23.0

708

4685

RK520

NOMESCO Finland

9.4

22.9

XQ800

NOMESCO Finland

Prick test

1.7

22.9

523

3202

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

22.8

2464

20350

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

22.7

562

3521

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

22.6

403

2289

J05AB01

ATC

aciclovir; systemic

1.4

22.6

1532

11824

R51.81

ICD-10 Finland

Facial pain NOS

2.5

22.6

184

753

N05BA12

ATC

alprazolam; oral

1.5

22.5

772

5233

N05BA01

ATC

diazepam; systemic, rectal

1.4

22.5

990

7073

M54.3

ICD-10 Finland

Sciatica

1.7

22.5

441

2579

D19

ICPC

Teeth/gum symptom/complaint

1.3

22.4

1915

15302

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

22.4

586

3722

VALMI

NOMESCO Finland

1.3

22.3

1781

14093

R01AD05

ATC

budesonide; nasal

1.6

22.2

575

3640

DDA00

NOMESCO Finland

Stapedotomy

6.2

22.1

A01AB09

ATC

miconazole; local oral

1.6

22.1

636

4140

D82

ICPC

Teeth/gum disease

1.3

22.1

2530

21034

H03AA01

ATC

levothyroxine sodium; systemic

1.3

22.1

1736

13703

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

22.1

171

681

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

21.4

22.1

H60

ICD-10 Finland

Otitis externa

1.9

21.9

322

1714

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

21.9

D07AC13

ATC

mometasone; topical

1.3

21.9

2168

17680

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

21.8

368

2052

J02AC02

ATC

itraconazole; systemic

1.4

21.8

1354

10295

H69.0

ICD-10 Finland

Patulous Eustachian tube

5.8

21.6

105

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

21.6

271

1357

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

21.5

1952

15720

G04BD12

ATC

mirabegron; oral

1.5

21.4

705

4736

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.3

21.2

199

875

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

21.1

445

2661

L29

ICPC

Musculoskeletal sympt/complt other

1.6

20.9

539

3406

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

13.4

20.9

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

+∞

20.8

Z01.7

ICD-10 Finland

Laboratory examination

1.5

20.7

789

5473

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

20.7

1755

13986

XF404

NOMESCO Finland

Ambulatory ECG

1.5

20.7

682

4582

UJH02

NOMESCO Finland

Anoscopy

1.9

20.7

326

1778

R83

ICPC

Respiratory infection other

1.3

20.6

1597

12564

A01

ICPC

Pain general/multiple sites

1.6

20.5

534

3388

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

20.4

3144

27039

J05AB11

ATC

valaciclovir; oral

1.4

20.3

947

6835

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

20.3

968

7021

R03DC03

ATC

montelukast; oral

1.4

20.2

1124

8378

P01AB01

ATC

metronidazole; oral, rectal

1.2

20.2

3024

25905

DHB50

NOMESCO Finland

Turbinoplasty

2.2

20.2

198

892

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

20.1

500

3133

A07AA02

ATC

nystatin; oral

1.7

20.0

443

2688

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

19.9

336

1879

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

19.8

3106

26728

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

19.8

689

4681

M01AB55

ATC

diclofenac, combinations; oral

1.6

19.8

502

3159

P03

ICPC

Feeling depressed

1.6

19.8

555

3585

P01

ICPC

Feeling anxious/nervous/tense

1.6

19.7

596

3921

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

19.7

834

5907

M48.0

ICD-10 Finland

Spinal stenosis

1.4

19.7

847

6022

D11

ICPC

Diarrhoea

1.5

19.6

724

4987

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

19.5

2497

20980

WZA90

NOMESCO Finland

Other doctors statement

1.3

19.4

1658

13211

M77.4

ICD-10 Finland

Metatarsalgia

1.7

19.4

388

2287

N41.1

ICD-10 Finland

Chronic prostatitis

2.3

19.3

175

758

H60.8

ICD-10 Finland

Other otitis externa

2.2

18.9

189

857

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

18.8

398

2383

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

18.8

283

1520

D07AD01

ATC

clobetasol; topical

1.4

18.8

1133

8557

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

18.7

1083

8124

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

18.6

293

1598

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.9

18.6

269

1424

TAB00

NOMESCO Finland

Lumbar puncture

1.8

18.6

317

1774

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

18.6

658

4490

SPAT1312

SPAT

General health counselling

1.3

18.6

2290

19135

DFF16

NOMESCO Finland

Speech-in-noise audiometry

190.3

18.5

RK420

NOMESCO Finland

190.3

18.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

18.5

1239

9515

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

12.3

18.5

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.7

18.5

127

474

R02

ICPC

Shortness of breath/dyspnoea

1.4

18.5

813

5801

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

18.4

542

3545

R03BA02

ATC

budesonide; inhalant

1.3

18.4

1246

9585

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

18.3

2406

20247

R49.01

ICD-10 Finland

Functional dysphonia

2.0

18.3

223

1104

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

18.3

1221

9372

J01EA01

ATC

trimethoprim; systemic

1.3

18.2

1738

14047

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

18.2

310

1738

R4110

NOMESCO Finland

Physiotherapy

1.3

18.2

2030

16752

H04

ICPC

Ear discharge

2.1

18.1

203

971

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

18.1

168

740

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

18.0

1417

11146

H65.2

ICD-10 Finland

Chronic serous otitis media

3.6

17.8

223

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

17.7

1802

14681

H02AB07

ATC

prednisone; oral

1.4

17.7

1021

7651

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

6.4

17.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

17.7

296

1650

U01

ICPC

Dysuria/painful urination

1.6

17.7

498

3224

K59.0

ICD-10 Finland

Constipation

1.7

17.7

352

2071

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

17.6

267

1439

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

17.5

1497

11911

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.4

17.5

146

608

R30.0

ICD-10 Finland

Dysuria

1.9

17.5

249

1309

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

17.5

528

3474

M79.7

ICD-10 Finland

Fibromyalgia

2.0

17.5

235

1213

N06AB03

ATC

fluoxetine; oral

1.4

17.4

908

6682

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

17.3

1045

7893

F13

ICPC

Eye sensation abnormal

2.1

17.2

189

896

R09

ICPC

Sinus symptom/complaint

1.6

17.1

492

3198

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

12.5

17.1

K03.80

ICD-10 Finland

Irradiated enamel

1.8

17.0

313

1799

J01MA01

ATC

ofloxacin; systemic

1.5

17.0

578

3907

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

17.0

387

2370

N06AB06

ATC

sertraline; oral

1.4

17.0

723

5123

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

17.0

633

4368

L14

ICPC

Leg/thigh symptom/complaint

1.6

17.0

481

3117

C10AA07

ATC

rosuvastatin; oral

1.3

16.8

1808

14823

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

3.0

16.8

332

E000001

ATC

1.3

16.5

1426

11354

ZXC10

NOMESCO Finland

Use of laser

2.2

16.5

162

733

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

16.4

590

4039

L16

ICPC

Ankle symptom/complaint

1.5

16.4

679

4783

K85

ICPC

Elevated blood pressure

1.4

16.4

1029

7815

D01AE16

ATC

amorolfine; topical

1.4

16.4

833

6102

N04BC05

ATC

pramipexole; oral

1.5

16.3

500

3300

K58

ICD-10 Finland

Irritable bowel syndrome

2.2

16.3

166

764

N06AX03

ATC

mianserin; oral

1.7

16.2

351

2120

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

16.2

999

7561

SPAT1097

SPAT

Recording of ECG

1.4

16.2

1024

7787

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

16.1

1473

11814

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

4.4

16.1

133

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

16.1

555

3763

M01AX01

ATC

nabumetone; oral

1.7

16.1

315

1848

S04

ICPC

Lump/swelling localized

1.5

16.0

605

4184

J01AA07

ATC

tetracycline; systemic

1.3

16.0

1041

7949

L86

ICPC

Back syndrome with radiating pain

1.6

16.0

390

2435

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

16.0

723

5183

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

15.9

138

585

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

15.9

286

1633

SPAT1260

SPAT

Consultation of another employee

1.3

15.9

1251

9832

D06BX01

ATC

metronidazole; topical

1.4

15.9

727

5224

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

15.9

1755

14428

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

6.0

15.8

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

15.8

276

1564

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.0

15.7

208

1068

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

15.7

506

3379

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

15.7

337

2032

R03BA01

ATC

beclometasone; inhalant

1.4

15.7

965

7302

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

15.6

811

5962

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

15.5

1293

10239

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

15.5

847

6279

SFA00

NOMESCO Finland

Small filling

1.4

15.5

897

6719

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

15.5

1705

14002

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

15.5

204

1045

SPAT1263

SPAT

Sampling

1.2

15.5

3115

27331

J01FF01

ATC

clindamycin; systemic

1.2

15.5

1995

16694

H61.8

ICD-10 Finland

Other specified disorders of external ear

3.1

15.3

268

M15

ICD-10 Finland

Polyarthrosis

1.7

15.3

325

1953

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

15.3

231

1246

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

15.2

364

2260

SPAT1310

SPAT

Counselling related to known health issue

1.2

15.2

2291

19504

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

15.1

398

2532

A02BA04

ATC

nizatidine; systemic

1.5

15.1

521

3535

D12

ICPC

Constipation

1.9

15.0

215

1135

L57.0

ICD-10 Finland

Actinic keratosis

1.5

14.9

604

4237

SBB10

NOMESCO Finland

Teeth copy

1.6

14.9

369

2311

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

14.9

769

5644

N30.0

ICD-10 Finland

Acute cystitis

1.4

14.9

896

6751

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

14.9

896

6753

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

14.9

218

1163

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

14.8

209

1097

L05

ICPC

Flank/axilla symptom/complaint

1.6

14.8

361

2257

F05

ICPC

Visual disturbance other

2.0

14.7

180

895

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

14.7

719

5232

R08

ICPC

Nose symptom/complaint other

1.9

14.7

210

1109

C09CA06

ATC

candesartan; oral

1.3

14.7

1545

12614

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

14.6

550

3803

G03DB01

ATC

dydrogesterone; oral

1.4

14.6

867

6518

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

14.6

151

700

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

14.6

469

3132

SPAT1325

SPAT

Vaccination

1.2

14.6

2398

20590

D03

ICPC

Heartburn

1.9

14.6

213

1134

M01AC01

ATC

piroxicam; systemic, rectal

1.3

14.5

966

7398

H02.3

ICD-10 Finland

Blepharochalasis

1.6

14.5

416

2708

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

2.8

14.4

326

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

2.6

14.4

107

422

N05AH04

ATC

quetiapine; oral

1.3

14.4

1072

8348

M75.8

ICD-10 Finland

Other shoulder lesions

1.9

14.4

216

1165

H57.1

ICD-10 Finland

Ocular pain

1.9

14.3

213

1144

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

14.3

815

6088

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.1

14.2

156

744

DFF50

NOMESCO Finland

Electronystagmography

9.1

14.1

H02BX01

ATC

methylprednisolone, combinations; systemic

1.6

14.1

348

2178

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

14.1

724

5312

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

14.1

1052

8193

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

14.0

643

4623

A97

ICPC

No disease

1.3

14.0

990

7649

R03AC03

ATC

terbutaline; inhalant

1.3

14.0

966

7438

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

14.0

117

492

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

13.9

520

3591

X15

ICPC

Vaginal symptom/complaint other

1.9

13.9

189

980

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.0

13.8

172

865

R05FB02

ATC

cough suppressants and expectorants

1.2

13.7

2790

24435

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

5.3

13.7

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

13.7

348

2198

M54.1

ICD-10 Finland

Radiculopathy

1.7

13.6

262

1530

R5599

NOMESCO Finland

Other rehabilitation service

2.0

13.6

170

854

SPAT1301

SPAT

No procedures

1.2

13.6

2207

18896

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

13.6

468

3174

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

13.6

151

723

H93.0

ICD-10 Finland

Degenerative and vascular disorders of ear

+∞

13.5

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

13.5

211

1154

F16

ICPC

Eyelid symptom/complaint

1.6

13.5

309

1899

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

13.5

331

2072

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

13.4

281

1684

D01BA02

ATC

terbinafine; oral; topical

1.2

13.4

1815

15242

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

13.3

189

997

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

13.3

310

1910

A27

ICPC

Fear of other disease NOS

1.7

13.3

287

1735

J20

ICD-10 Finland

Acute bronchitis

1.4

13.3

634

4591

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

13.3

5462

50838

J45

ICD-10 Finland

Asthma

1.4

13.2

628

4543

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

13.2

1120

8881

H01.0

ICD-10 Finland

Blepharitis

1.6

13.2

355

2274

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

13.1

456

3102

X58

ICD-10 Finland

Exposure to other specified factors

1.3

13.1

912

7031

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

13.1

1315

15916

N06AA12

ATC

doxepin; systemic

1.6

13.0

360

2319

M76.0

ICD-10 Finland

Gluteal tendinitis

2.2

13.0

128

583

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

12.9

866

6635

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.2

12.9

715

M19.8

ICD-10 Finland

Other specified arthrosis

1.8

12.8

231

1322

R03BA08

ATC

ciclesonide; inhalant

1.4

12.8

542

3835

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.7

12.8

145

R03BA05

ATC

fluticasone; inhalant

1.3

12.8

1206

9697

D07AB08

ATC

desonide; topical

1.4

12.8

687

5078

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

12.8

579

4155

K03.00

ICD-10 Finland

Approximal wear

1.6

12.7

325

2054

K07.61

ICD-10 Finland

Cracking jaw joint

2.3

12.7

118

524

J01AA04

ATC

lymecycline; systemic

1.3

12.7

851

6521

H69.8

ICD-10 Finland

Other specified disorders of Eustachian tube

5.2

12.6

A01AB04

ATC

amphotericin B; local oral

1.6

12.6

316

1988

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

12.6

352

2276

M20.2

ICD-10 Finland

Hallux rigidus

1.8

12.6

222

1265

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

12.6

1901

16136

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.3

12.6

794

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

12.6

1089

8657

N05AB04

ATC

prochlorperazine; systemic, rectal

2.0

12.6

149

737

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

12.5

284

1742

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

12.5

472

3268

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

12.5

R15

ICD-10 Finland

Faecal incontinence

1.9

12.5

172

900

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

12.5

668

4937

H10

ICD-10 Finland

Conjunctivitis

1.5

12.3

377

2492

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

12.3

756

5714

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

12.3

578

4171

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

12.3

552

3955

D09

ICPC

Nausea

1.7

12.3

228

1320

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

12.2

1497

12415

H80

ICD-10 Finland

Otosclerosis

14.3

12.2

M75

ICD-10 Finland

Shoulder lesions

1.7

12.2

271

1653

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

12.2

229

1331

S08

ICPC

Skin colour change

1.6

12.2

316

2009

N05CD07

ATC

temazepam; oral

1.3

12.2

809

6193

RK320

NOMESCO Finland

3.2

12.2

194

L11

ICPC

Wrist symptom/complaint

1.4

12.1

494

3469

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

15.9

12.1

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.1

12.1

129

610

UDM02

NOMESCO Finland

Sinoscopy

2.0

12.1

145

719

A05

ICPC

Feeling ill

1.6

12.1

328

2109

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.7

12.1

247

1471

H93.9

ICD-10 Finland

Disorder of ear, unspecified

6.9

12.0

J01DA06

ATC

[U] cefuroxime; systemic

1.3

12.0

1022

8101

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

12.0

1921

16388

SPAT1240

SPAT

Therapeutic discussion

1.4

12.0

636

4691

C07AB02

ATC

metoprolol; systemic

1.3

12.0

1342

11015

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.5

11.9

457

3172

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

11.9

366

2425

L84

ICPC

Back syndrome without radiat pain

1.6

11.9

277

1710

C10AA05

ATC

atorvastatin; oral

1.2

11.9

2801

24790

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

11.9

3056

27250

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

11.8

473

3313

R11

ICD-10 Finland

Nausea and vomiting

1.5

11.8

470

3288

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

11.8

293

1841

I84

ICD-10 Finland

Hemorrhoids

1.8

11.8

194

1080

-60

ICPC

Result test/procedure

1.5

11.8

390

2628

J01MA06

ATC

norfloxacin; oral

1.3

11.8

918

7190

H53.2

ICD-10 Finland

Diplopia

1.8

11.8

199

1117

G04CB02

ATC

dutasteride; oral

1.6

11.7

336

2187

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.7

11.7

217

1255

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

11.7

557

4034

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.3

11.7

104

451

C10AA03

ATC

pravastatin; oral

1.5

11.7

454

3164

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

11.7

729

5526

C09CA01

ATC

losartan; oral

1.2

11.6

1683

14207

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

11.5

337

2206

M19

ICD-10 Finland

Other arthrosis

2.0

11.5

151

776

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.9

11.5

230

C05AA01

ATC

hydrocortisone; rectal, topical

1.5

11.5

353

2337

M01AH03

ATC

valdecoxib; oral

1.5

11.4

445

3104

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

11.4

223

1312

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.3

11.4

710

5381

R29

ICPC

Respiratory symptom/complaint other

1.5

11.4

392

2663

N03AX09

ATC

lamotrigine; oral

1.6

11.3

275

1719

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

11.3

347

2295

Z97.8

ICD-10 Finland

Presence of other specified devices

7.8

11.3

N64.4

ICD-10 Finland

Mastodynia

1.9

11.3

160

846

N39.3

ICD-10 Finland

Stress incontinence

1.4

11.3

457

3210

WX290

NOMESCO Finland

Other blockade of nerve

1.2

11.3

3136

28118

WX320

NOMESCO Finland

Spinalanesthesy

1.2

11.3

1594

13424

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

11.2

473

3348

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

11.2

1133

9179

R06AX13

ATC

loratadine; oral

1.3

11.2

1005

8023

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.5

11.2

378

2556

R07

ICPC

Sneezing/nasal congestion

1.5

11.2

359

2404

H26.4

ICD-10 Finland

After-cataract

1.4

11.1

509

3659

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.3

11.0

408

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

11.0

270

1695

A01AC01

ATC

triamcinolone; local oral

2.1

11.0

118

560

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

11.0

205

1189

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

2.9

11.0

226

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

11.0

828

6453

D07XC01

ATC

betamethasone, combinations; topical

1.3

11.0

794

6150

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.7

11.0

207

1208

RL210

NOMESCO Finland

4.1

11.0

100

L28

ICPC

Limited function/disability (L)

1.3

11.0

965

7684

F32

ICD-10 Finland

Depressive episode

1.6

10.9

309

2009

J01

ICD-10 Finland

Acute sinusitis

1.6

10.9

296

1905

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

10.9

824

6423

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

10.9

1295

10693

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

10.9

142

729

P20

ICPC

Memory disturbance

1.4

10.9

654

4926

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.1

10.8

112

525

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

10.8

768

5936

P76

ICPC

Depressive disorder

1.5

10.7

367

2489

S01GX05

ATC

lodoxamide; ophthalmic

2.3

10.7

432

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

2.1

10.7

112

527

A03

ICPC

Fever

1.3

10.7

952

7586

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

10.7

423

2958

A10BA02

ATC

metformin; oral

0.8

10.7

1414

16683

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

5.4

10.7

U05

ICPC

Urination problems other

1.6

10.7

276

1756

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

21.5

10.7

R31

ICD-10 Finland

Unspecified haematuria

1.4

10.7

589

4379

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

10.6

2873

25662

JG1JB

NOMESCO Finland

Defekography with X-ray

2.9

10.6

214

R96

ICPC

Asthma

1.4

10.6

548

4026

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.2

10.6

1480

12436

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.4

10.6

389

R06AX18

ATC

acrivastine; oral

1.8

10.6

183

1037

I49

ICD-10 Finland

Other cardiac arrhythmias

2.2

10.6

105

482

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.4

10.6

352

UJD02

NOMESCO Finland

Gastroscopy

1.6

10.6

303

1976

F01

ICPC

Eye pain

1.8

10.5

166

914

D07AA02

ATC

hydrocortisone; topical

1.3

10.5

850

6690

Z00.8

ICD-10 Finland

Other general examinations

1.4

10.5

441

3119

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

10.5

1265

10461

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

10.5

606

4540

F51

ICD-10 Finland

Nonorganic sleep disorders

1.7

10.5

197

1149

D25

ICPC

Abdominal distension

2.1

10.4

117

568

C04AE01

ATC

ergoloid mesylates; systemic

4.3

10.4

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

1.9

10.4

141

736

RK110

NOMESCO Finland

3.2

10.4

167

G01AA10

ATC

clindamycin; vaginal

1.3

10.4

950

7597

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

10.4

205

1213

A02BX02

ATC

sucralfate; oral

1.6

10.4

260

1640

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

12.0

10.3

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

10.3

513

3745

C10AC01

ATC

colestyramine; oral

1.8

10.3

170

952

Z50.1

ICD-10 Finland

Other physical therapy

1.5

10.3

369

2531

L09

ICPC

Arm symptom/complaint

1.6

10.3

259

1635

K14.61

ICD-10 Finland

Glossodynia

3.0

10.3

191

C10AX09

ATC

ezetimibe; oral

1.3

10.3

734

5678

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

10.3

539

3972

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.1

10.2

108

511

J01CA08

ATC

pivmecillinam; oral

1.2

10.2

2729

24339

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

10.2

1772

15212

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

10.2

203

1204

N81.6

ICD-10 Finland

Rectocele

1.4

10.2

416

2929

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.6

10.2

269

1723

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

10.1

168

939

U07

ICPC

Urine symptom/complaint other

1.5

10.1

352

2396

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

10.1

865

6858

R03AC13

ATC

formoterol; inhalant

1.5

10.1

312

2071

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

10.1

381

2641

N05AH02

ATC

clozapine; systemic

0.3

10.1

623

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

10.1

313

2082

H82

ICPC

Vertiginous syndrome

2.1

10.0

111

534

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

10.0

1780

15312

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

10.0

521

3835

D02AE01

ATC

carbamide; topical

1.4

10.0

432

3073

J32.4

ICD-10 Finland

Chronic pansinusitis

2.3

10.0

415

G43

ICD-10 Finland

Migraine

1.7

10.0

216

1311

AA1CG

SPAT

3.0

9.9

185

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.3

9.9

679

5219

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

9.9

707

5470

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

9.9

1352

11332

I77.0

ICD-10 Finland

Arteriovenous fistula, acquired

7.6

9.9

KED33

NOMESCO Finland

Transurethral incision of prostate

2.4

9.8

323

SPAT1053

SPAT

Memory test

1.3

9.8

848

6733

H27

ICPC

Fear of ear disease

2.5

9.8

305

H81.2

ICD-10 Finland

Vestibular neuronitis

2.0

9.8

123

624

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

9.8

496

3631

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.7

9.8

246

3640

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

9.8

312

2087

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.9

9.7

131

682

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.7

9.7

181

1053

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

1.8

9.7

157

874

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

9.7

398

2804

H65.0

ICD-10 Finland

Acute serous otitis media

2.2

9.7

409

DE2DM

NOMESCO Finland

Very extensive 3 T MRI of internal auditory canal

55.0

9.6

K60.1

ICD-10 Finland

Chronic anal fissure

1.8

9.6

150

823

C10AA04

ATC

fluvastatin; oral

1.4

9.6

524

3886

S16

ICPC

Bruise/contusion

1.7

9.6

182

1066

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.3

9.6

360

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.5

9.6

288

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

9.6

273

1779

U71

ICPC

Cystitis/urinary infection other

1.5

9.6

371

2589

K14.60

ICD-10 Finland

Glossopyrosis

3.3

9.5

140

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.5

9.5

299

1992

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.7

9.5

197

1183

C10AA01

ATC

simvastatin; oral

1.2

9.5

3109

28125

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

9.5

432

3104

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

3.5

9.5

120

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.2

9.5

408

EB1AA

SPAT

1.5

9.5

301

2014

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

9.4

402

2855

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

9.4

242

1541

H93.3

ICD-10 Finland

Disorders of acoustic nerve

+∞

9.4

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.0

9.3

120

617

H83.1

ICD-10 Finland

Labyrinthine fistula

12.3

9.3

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

9.3

771

6084

N06AB05

ATC

paroxetine; oral

1.4

9.3

403

2870

ACC51

NOMESCO Finland

Release of median nerve

1.4

9.3

467

3418

M67.4

ICD-10 Finland

Ganglion

1.4

9.3

401

2853

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

9.3

1980

17306

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

2.7

9.3

229

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

3.6

9.3

112

TDA90

SPAT

1.9

9.2

127

667

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.2

9.2

398

CS494

NOMESCO Finland

Other visual field testing

1.9

9.2

131

695

D93

ICPC

Irritable bowel syndrome

2.5

9.2

283

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

9.2

176

1031

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

9.2

227

1431

P01BA02

ATC

hydroxychloroquine; oral

1.4

9.2

536

4021

ZXC60

NOMESCO Finland

Application of heat

2.0

9.2

110

551

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.7

9.2

174

1018

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

9.1

1421

12056

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.1

9.1

156

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

1.4

9.1

354

2471

SGA05

NOMESCO Finland

Very demanding and lengthy opening and dilatation of root canal of tooth

1.4

9.1

358

2505

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

1.9

9.1

124

651

N02CC05

ATC

almotriptan; oral

1.6

9.1

214

1331

M54.8

ICD-10 Finland

Other dorsalgia

1.6

9.1

238

1521

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

9.1

235

1499

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

9.1

269

1772

A06AD11

ATC

lactulose; oral

1.3

9.0

837

6701

N06AG02

ATC

moclobemide; oral

1.5

9.0

293

1967

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

9.0

1781

15455

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.8

9.0

160

917

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

9.0

267

1757

SPAT1211

SPAT

Application of soft bandage

1.3

9.0

554

4188

N05AC02

ATC

thioridazine; oral

0.4

9.0

802

RK530

NOMESCO Finland

36.7

9.0

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

9.0

524

3930

G04BD08

ATC

solifenacin; oral

1.4

9.0

411

2955

R06AX26

ATC

fexofenadine; oral

1.4

9.0

411

2958

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.0

9.0

113

577

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

9.0

234

1493

S12

ICPC

Insect bite/sting

1.4

9.0

501

3731

R49.03

ICD-10 Finland

Atrophic dysphonia

2.4

9.0

301

M76.6

ICD-10 Finland

Achilles tendinitis

1.5

8.9

286

1917

XCK00

NOMESCO Finland

Perimetry

1.4

8.9

406

2919

SPAT1044

SPAT

Tympanometry

2.0

8.9

116

597

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.8

8.9

152

863

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

8.9

676

5272

D06BB03

ATC

aciclovir; topical

1.5

8.9

309

2107

B07.9

ICD-10 Finland

Verruca simplex

1.7

8.9

194

1184

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.5

8.9

322

2214

R01BA01

ATC

phenylpropanolamine; oral

1.4

8.9

349

2441

D01AE15

ATC

terbinafine; topical

1.4

8.9

431

3137

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

8.9

138

760

M77.0

ICD-10 Finland

Medial epicondylitis

1.8

8.9

153

871

K05

ICPC

Irregular heartbeat other

1.7

8.8

180

1078

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.8

8.8

134

732

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

1.8

8.8

158

909

N30

ICD-10 Finland

Cystitis

1.4

8.8

437

3194

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

8.8

196

1201

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.6

8.8

243

K25

ICPC

Fear of hypertension

1.6

8.8

225

1431

L90

ICPC

Osteoarthrosis of knee

1.4

8.7

388

2777

J01FA01

ATC

erythromycin; systemic

1.3

8.7

867

7003

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.7

8.7

159

923

R75

ICPC

Sinusitis acute/chronic

1.5

8.7

260

1718

R03BC03

ATC

nedocromil; inhalant

1.4

8.7

455

3357

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.4

8.7

500

3747

M65.3

ICD-10 Finland

Trigger finger

1.5

8.6

267

1777

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.1

8.6

407

A69.2

ICD-10 Finland

Lyme disease

1.5

8.6

317

2188

R04

ICPC

Breathing problem other

1.6

8.6

199

1235

R01AX03

ATC

ipratropium bromide; nasal

1.8

8.6

128

697

C01CA24

ATC

epinephrine; parenteral

1.4

8.5

360

2552

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

8.5

597

4607

D22

ICD-10 Finland

Melanocytic naevi

1.5

8.5

252

1663

XQ802

NOMESCO Finland

Epicutan test

1.6

8.5

235

1527

PA5AC

NOMESCO Finland

Angiography of arteries to the face with X-ray

20.0

8.5

SGA01

NOMESCO Finland

Tooth opening as first aid

1.2

8.5

987

8124

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

2.9

8.4

170

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

0.1

8.4

296

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.3

8.4

332

N06AX12

ATC

bupropion; oral

1.4

8.4

337

2372

H73.1

ICD-10 Finland

Chronic myringitis

12.7

8.4

K07.6

ICD-10 Finland

Temporomandibular joint disorders

2.8

8.4

193

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.4

8.3

331

2323

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

8.3

305

2106

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

8.3

DFF80

NOMESCO Finland

Measurement of tinnitus frequency

+∞

8.3

Z45.3

ICD-10 Finland

Adjustment and management of implanted hearing device

+∞

8.3

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

8.3

491

3693

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.8

8.3

135

753

104

Kela drug reimbursment

Thyroid insufficiency

1.4

8.3

456

3389

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

8.3

166

991

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.0

8.3

100

501

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

1.8

8.3

137

772

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

1.9

8.3

115

610

UDQ02

NOMESCO Finland

Direct laryngoscopy

2.7

8.3

196

S06.0

ICD-10 Finland

Concussion

1.3

8.2

614

4782

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

8.2

1471

12643

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.3

8.2

589

4565

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.0

8.2

483

R78

ICPC

Acute bronchitis/bronchiolitis

1.8

8.2

132

737

H71

ICD-10 Finland

Cholesteatoma of middle ear

2.8

8.2

181

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.3

8.2

472

R49.0

ICD-10 Finland

Dysphonia

2.0

8.1

102

522

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

8.1

698

5540

R14

ICD-10 Finland

Flatulence and related conditions

2.5

8.1

248

A02BDXX

ATC

1.6

8.1

218

1406

L60.0

ICD-10 Finland

Ingrowing nail

1.5

8.1

247

1643

G93.0

ICD-10 Finland

Cerebral cysts

4.2

8.0

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

8.0

454

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.5

8.0

243

G04BD11

ATC

fesoterodine; oral

1.7

8.0

172

1047

B02AA02

ATC

tranexamic acid; systemic

1.2

8.0

929

7641

M95.0

ICD-10 Finland

Acquired deformity of nose

3.0

8.0

149

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

8.0

163

978

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

8.0

652

5137

L92

ICPC

Shoulder syndrome

1.8

8.0

140

804

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

1.8

8.0

134

758

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.3

8.0

755

6065

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

8.0

419

3091

K02

ICPC

Pressure/tightness of heart

1.8

7.9

141

810

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

7.9

692

5502

U13

ICPC

Bladder symptom/complaint other

1.6

7.9

181

1121

SPAT1058

SPAT

PEF monitoring instruction

1.3

7.9

500

3802

UJD10

SPAT

2.0

7.9

450

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

7.9

550

4242

S02.51

ICD-10 Finland

Fracture of tooth, open

1.3

7.9

653

5157

N06

ICPC

Sensation disturbance other

2.3

7.9

296

A99

ICPC

Disease/condition unspecnature/site

1.3

7.9

485

3675

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.7

7.8

183

R06.2

ICD-10 Finland

Wheezing

1.5

7.8

249

1670

N02CC04

ATC

rizatriptan; oral

1.4

7.8

327

2318

-1

ICD-10 Finland

1.6

7.8

196

1241

N04AA02

ATC

biperiden; systemic

0.4

7.8

753

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

3.9

7.8

SPAT1283

SPAT

Restricted health certificate

1.2

7.8

980

8131

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.8

7.8

129

727

A08

ICPC

Swelling

1.5

7.8

241

1607

H70

ICPC

Otitis externa

1.8

7.8

119

651

H81.8

ICD-10 Finland

Other disorders of vestibular function

4.3

7.8

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

1.6

7.8

189

1187

NBG10

NOMESCO Finland

Acromioplastia

1.7

7.8

166

1009

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

7.8

1523

13188

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

10.8

7.8

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

7.8

440

3289

J33.8

ICD-10 Finland

Other polyp of sinus

1.8

7.8

123

684

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.6

7.7

210

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.8

7.7

132

751

130

Kela drug reimbursment

Malignant tumour

0.7

7.7

293

4035

N06AA10

ATC

nortriptyline; systemic

1.8

7.7

134

767

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

7.7

237

1577

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

1.2

7.7

868

7116

Z00.0

ICD-10 Finland

General medical examination

1.2

7.7

1196

10141

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

2.0

7.7

439

G51.0

ICD-10 Finland

Bell palsy

1.7

7.7

146

856

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.5

7.7

250

1683

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

7.7

1050

8790

M01AB08

ATC

etodolac; oral

1.3

7.7

482

3660

B37.0

ICD-10 Finland

Candidal stomatitis

2.3

7.7

294

C08CA05

ATC

nifedipine; systemic

1.4

7.7

365

2650

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

7.7

148

876

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.4

7.7

340

2439

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

7.6

1246

10614

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.8

7.6

1132

13251

38699

ICD-8 Finland

4.3

7.6

S01GX02

ATC

levocabastine; ophthalmic

1.4

7.6

361

2622

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.0

7.6

422

P72

ICPC

Schizophrenia

0.4

7.6

649

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.3

7.6

648

5142

EB1SA

SPAT

1.5

7.6

212

1381

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

7.6

2075

18469

E000002

ATC

1.3

7.6

687

5491

L20

ICPC

Joint symptom/complaint NOS

1.6

7.5

204

1318

G44.8

ICD-10 Finland

Other specified headache syndromes

2.1

7.5

355

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.3

7.5

780

6332

L19

ICPC

Muscle symptom/complaint NOS

1.7

7.5

139

810

S01GX09

ATC

olopatadine; ophthalmic

1.7

7.5

150

897

H93.8

ICD-10 Finland

Other specified disorders of ear

6.1

7.5

XA800

NOMESCO Finland

Neuropsychological investigation

1.5

7.5

242

1630

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

7.5

726

5848

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

7.5

425

3177

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.5

7.5

252

1714

PA6AD

NOMESCO Finland

CT of neck arteries

2.2

7.5

337

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

7.4

259

1773

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.4

7.4

292

2046

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

7.4

124

702

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.2

7.4

842

6912

C01DA14

ATC

isosorbide mononitrate; oral

1.2

7.4

803

6561

R4120

NOMESCO Finland

Occupational therapy

1.4

7.4

391

2892

L83

ICPC

Neck syndrome

2.5

7.3

223

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.7

7.3

139

817

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.3

7.3

576

4518

H74.1

ICD-10 Finland

Adhesive middle ear disease

4.7

7.3

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

7.3

980

8190

38990

ICD-8 Finland

Other deafness, Partialis uni-sive bilateralis

+∞

7.3

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

2.1

7.3

381

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.5

7.3

225

K96

ICPC

Haemorrhoids

1.7

7.3

142

842

M01AB01

ATC

indometacin; systemic, rectal

1.3

7.3

453

3440

H25.0

ICD-10 Finland

Senile incipient cataract

1.4

7.3

337

2439

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

7.2

193

1244

M43.1

ICD-10 Finland

Spondylolisthesis

1.5

7.2

237

1599

M75.5

ICD-10 Finland

Bursitis of shoulder

1.7

7.2

131

760

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

7.2

188

1204

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

7.2

1277

14734

M01AC02

ATC

tenoxicam; systemic, rectal

1.4

7.2

313

2236

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

7.2

393

2919

PA2GT

NOMESCO Finland

Embolisation of arterio-venous malformation of the brain

15.7

7.2

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

7.2

525

4077

H00.1

ICD-10 Finland

Chalazion

1.5

7.2

199

1296

G45.4

ICD-10 Finland

Transient global amnesia

1.7

7.2

133

779

K03.1

ICD-10 Finland

Abrasion of teeth

1.6

7.2

162

1002

H90

ICD-10 Finland

Conductive and sensorineural hearing loss

5.8

7.2

XF405

NOMESCO Finland

Symptom ECG

2.4

7.2

246

A01AB10

ATC

natamycin; local oral

1.6

7.2

163

1010

R19.4

ICD-10 Finland

Change in bowel habit

1.7

7.1

132

771

R49.09

ICD-10 Finland

Unspecified dysphonia

2.2

7.1

310

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

7.1

295

2091

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.5

7.1

207

1361

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

7.1

222

1483

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

2.0

7.1

392

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.7

7.1

135

795

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

7.1

225

1513

I44.0

ICD-10 Finland

Atrioventricular block, first degree

2.1

7.1

358

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

2.9

7.1

143

F73

ICPC

Eye infection/inflammation other

1.8

7.1

107

586

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

7.1

456

3483

E000007

ATC

1.4

7.0

320

2307

N06AB08

ATC

fluvoxamine; oral

1.6

7.0

173

1093

D18

ICPC

Change in faeces/bowel movements

1.8

7.0

120

684

R20.0

ICD-10 Finland

Anaesthesia of skin

2.6

7.0

190

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

10.0

7.0

L10

ICPC

Elbow symptom/complaint

1.5

7.0

249

1711

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

1.7

7.0

138

823

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

7.0

705

5710

H52.2

ICD-10 Finland

Astigmatism

2.0

7.0

398

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

7.0

461

3531

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.3

7.0

724

5882

S02CA02

ATC

flumetasone and antiinfectives; otic

1.4

7.0

323

2337

N03AF01

ATC

carbamazepine; oral, rectal

1.4

7.0

305

2184

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.4

6.9

346

2534

K03.08

ICD-10 Finland

Other wear and tear of the teeth

1.7

6.9

130

764

R60.0

ICD-10 Finland

Localized oedema

1.3

6.9

666

5362

E000006

ATC

1.3

6.9

416

3145

C01BC04

ATC

flecainide; systemic

1.5

6.9

214

1432

R55

ICD-10 Finland

Syncope and collapse

1.3

6.9

624

4985

H48

ICPC

Ear, Clarification/discussion RFE/demand

5.8

6.9

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.5

6.9

224

1512

1220

FHL

Arthroscopy

1.5

6.9

234

1594

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.8

6.9

106

588

L71.8

ICD-10 Finland

Other rosacea

2.0

6.9

447

R06AE53

ATC

cyclizine, combinations; systemic

2.6

6.8

187

B02.9

ICD-10 Finland

Zoster without complication

1.4

6.8

331

2412

R49.08

ICD-10 Finland

Other specified dysphonia

1.7

6.8

126

738

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.3

6.8

646

5190

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.5

6.8

201

1330

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

4.8

6.8

R06.4

ICD-10 Finland

Hyperventilation

1.9

6.8

492

RK120

NOMESCO Finland

4.3

6.8

J45.1

ICD-10 Finland

Nonallergic asthma

1.3

6.8

409

3090

S74

ICPC

Dermatophytosis

1.8

6.8

111

627

Z57.0

ICD-10 Finland

Occupational exposure to noise

10.9

6.8

T16

ICD-10 Finland

Foreign body in ear

2.6

6.8

179

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.3

6.8

428

3259

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.2

6.8

274

K57

ICD-10 Finland

Diverticular disease of intestine

1.7

6.8

125

732

TQW99

NOMESCO Finland

Other minor procedure on skin

1.4

6.8

287

2044

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

6.8

374

2789

DFF05

SPAT

4.0

6.7

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

0.7

6.7

240

3338

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

6.7

1360

11801

A07EA02

ATC

hydrocortisone; rectal

1.7

6.7

137

825

A29

ICPC

General symptom/complaint other

1.3

6.7

673

5444

EMB10

NOMESCO Finland

Tonsillectomy

1.4

6.7

281

1997

29580

ICD-8 Finland

Schizophrenia, Other

0.1

6.7

198

SPE00

NOMESCO Finland

Fitting and preparation of metal structure partial teeth prosthesis

1.8

6.7

104

576

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

6.7

293

2098

K29

ICPC

Cardiovascular sympt/complt other

1.5

6.7

239

1646

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

2.3

6.7

237

G45.3

ICD-10 Finland

Amaurosis fugax

1.8

6.7

104

578

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

1.5

6.7

217

1468

S01

ICPC

Pain/tenderness of skin

1.5

6.7

243

1680

SPAT1210

SPAT

Application of cast or individual aid

1.5

6.7

243

1681

Y06

ICPC

Prostate symptom/complaint

1.6

6.6

146

897

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

6.6

507

3969

A10AE04

ATC

insulin glargine; parenteral

0.8

6.6

345

4528

L91

ICPC

Osteoarthrosis other

1.8

6.6

103

570

J01DA08

ATC

[U] cefaclor; oral

1.3

6.6

612

4908

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.2

6.6

692

5628

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

6.6

118

685

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.5

6.6

187

1224

M50

ICD-10 Finland

Cervical disc disorders

2.4

6.6

213

R1260

NOMESCO Finland

Evaluation of communicative skills

2.0

6.6

401

T90

ICPC

Diabetes non-insulin dependent

0.8

6.6

1180

13597

F34.1

ICD-10 Finland

Dysthymia

1.5

6.5

199

1327

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

6.5

1124

9617

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.4

6.5

267

1889

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

6.5

326

2390

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

6.5

468

3632

N41.0

ICD-10 Finland

Acute prostatitis

1.8

6.5

104

583

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

5.0

6.5

C08DA01

ATC

verapamil; systemic

1.5

6.5

235

1628

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.5

6.4

181

1184

S79

ICPC

Neoplasm skin benign/unspecified

1.8

6.4

104

586

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

2.9

6.4

128

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.3

6.4

386

2919

PA5JT

NOMESCO Finland

Embolisation of very extensive arterio-venous malformation of carotis externa area

69.9

6.4

K60.2

ICD-10 Finland

Anal fissure, unspecified

1.9

6.4

497

N02CC07

ATC

frovatriptan; oral

1.5

6.4

202

1357

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.2

6.4

261

R03AK08

ATC

formoterol and beclometasone; inhalant

1.5

6.4

212

1439

Q28.0

ICD-10 Finland

Arteriovenous malformation of precerebral vessels

14.3

6.4

H00.00

ICD-10 Finland

Hordeolum

1.5

6.4

209

1417

7177A

ICD-9 Finland

Internal derangement of knee, Chondromalacia of patella

1.9

6.4

418

XKC03

NOMESCO Finland

Water cystometry

1.5

6.4

177

1157

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.2

6.4

283

SPAT1202

SPAT

Intra-articular injection

1.5

6.3

189

1254

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.0

6.3

343

G43.3

ICD-10 Finland

Complicated migraine

2.0

6.3

393

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

6.3

1364

11896

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

6.3

314

2303

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

6.3

555

4420

J33.9

ICD-10 Finland

Nasal polyp, unspecified

2.2

6.3

276

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

6.3

247

1733

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.5

6.3

202

1362

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

1.7

6.3

121

720

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

1.9

6.3

451

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.2

6.3

277

WX200

NOMESCO Finland

Interscalenous plexus blockade

1.7

6.3

122

725

SPAT1034

SPAT

Removal of foreign body from ear canal

3.5

6.3

K64.0

ICD-10 Finland

First degree haemorrhoids

2.0

6.3

399

S01KA02

ATC

hypromellose; ophthalmic

1.7

6.3

113

657

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.7

6.3

120

710

DFF20

NOMESCO Finland

Audiometry for children

+∞

6.2

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.0

6.2

387

UJF32

SPAT

1.8

6.2

100

560

M75.2

ICD-10 Finland

Bicipital tendinitis

1.6

6.2

144

900

H69.9

ICD-10 Finland

Eustachian tube disorder, unspecified

3.3

6.2

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.5

6.2

213

1456

N05AA01

ATC

chlorpromazine; systemic, rectal

0.4

6.2

508

K07.58

ICD-10 Finland

Other abnormal function of teeth and jaws

3.1

6.2

100

DC1AI

NOMESCO Finland

Cone beam CT of ear

26.7

6.2

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.7

6.2

130

789

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

4.3

6.2

DFF00

SPAT

3.3

6.2

R23

ICD-10 Finland

Other skin changes

2.1

6.2

305

S80.0

ICD-10 Finland

Contusion of knee

1.3

6.2

365

2752

M35.7

ICD-10 Finland

Hypermobility syndrome

2.0

6.2

354

N76.0

ICD-10 Finland

Acute vaginitis

1.4

6.2

251

1776

N02CC03

ATC

zolmitriptan; nasal, oral

1.4

6.2

294

2142

M43.0

ICD-10 Finland

Spondylolysis

1.8

6.2

105

601

G93.2

ICD-10 Finland

Benign intracranial hypertension

5.0

6.2

H11.4

ICD-10 Finland

Other conjunctival vascular disorders and cysts

2.5

6.2

183

A07EC01

ATC

sulfasalazine; oral, rectal

1.3

6.1

492

3874

M01AE52

ATC

naproxen and esomeprazole; oral

1.5

6.1

200

1353

WX723

NOMESCO Finland

CPAP therapy

1.5

6.1

200

1353

C08CA01

ATC

amlodipine; oral

1.1

6.1

2455

22378

K05.1

ICD-10 Finland

Chronic gingivitis

1.3

6.1

412

3167

R4130

NOMESCO Finland

Speech therapy

1.7

6.1

121

726

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

6.1

110

640

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

6.1

297

2171

F02

ICPC

Red eye

1.4

6.1

236

1656

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

6.1

313

2309

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.6

6.1

160

1034

N05AD01

ATC

haloperidol; systemic

0.5

6.1

1111

SPAT1216

SPAT

Assessment of functional ability

1.2

6.1

887

7472

H60.3

ICD-10 Finland

Other infective otitis externa

1.7

6.1

113

663

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

6.0

403

3095

S22.3

ICD-10 Finland

Fracture of rib

1.3

6.0

359

2712

SPAT1050

SPAT

Extensive neurological examination

1.7

6.0

118

703

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.4

6.0

308

2268

N06AX17

ATC

milnacipran; oral

2.0

6.0

365

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

1.7

6.0

118

706

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.7

6.0

111

653

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.1

6.0

281

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

7732

63988

1.83

147.01

4.6

4.1

10.8

12.4

mm/h

21.56

7191

59319

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9027

79223

2.10

135.26

5.7

4.7

2.0

2.1

mu/l

0.16

8319

72690

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7831

66022

1.77

127.92

4.7

4.0

14.8

pmol/l

0.01

7155

60210

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7852

67219

1.70

109.96

7.6

7.8

74.8

78.3

u/l

9.47

7366

63446

(3037467) Urinalysis macro (dipstick) panel - Urine

7077

59116

1.62

107.90

4.8

4.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9503

86528

2.21

106.17

15.1

14.2

20.9

23.9

mg/l

15.69

7447

68618

(3019550) Sodium [Moles/volume] in Serum or Plasma

9700

89631

2.32

94.86

17.1

16.2

139.9

139.7

mmol/l

10.27

9510

87450

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4543

34943

1.54

93.95

2.1

2.0

98.8

95.7

pmol/l

3.90

2301

18060

(3023103) Potassium [Moles/volume] in Serum or Plasma

9711

89900

2.31

92.37

17.3

16.3

4.0

mmol/l

4.19

9508

87554

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9271

84441

1.95

91.19

5.1

4.5

5.8

6.0

mmol/l

17.07

8545

77245

(3031040) Bacteria [#/volume] in Urine by Automated count

6701

56301

1.54

89.90

5.0

4.3

612.0

1691.6

e6/l

1.12

763

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4899

39099

1.48

80.03

5.7

6.1

1.2

mmol/l

5.52

4398

35513

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9872

92727

2.42

78.70

11.7

10.6

25.8

26.7

u/l

3.40

9566

89546

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5298

43097

1.47

77.56

6.2

6.8

1.2

mmol/l

3.61

4476

36359

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2590

18252

1.56

75.87

1.3

1.5

1.9

u/ml

0.76

595

4900

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4511

35750

1.46

74.41

2.9

2.8

125.7

135.1

ug/l

0.66

4152

33171

(3013115) Eosinophils [#/volume] in Blood

5434

44723

1.45

72.89

6.2

0.2

e9/l

0.65

4737

39027

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9472

87976

1.91

71.91

5.6

4.9

2.8

mmol/l

0.18

8756

81256

(3007461) Platelets [#/volume] in Blood

10104

96315

3.13

71.77

22.9

20.9

249.4

251.8

e9/l

3.36

9868

93849

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2176

14906

1.58

71.51

1.3

28.4

35.5

iu/ml

1.01

595

4778

(3035941) MCH [Entitic mass]

10105

96355

3.13

71.24

22.8

20.8

30.4

30.3

0.87

9982

95063

(3024731) MCV [Entitic volume]

10105

96367

3.12

70.99

22.8

20.8

91.1

0.28

9982

95074

(3026361) Erythrocytes [#/volume] in Blood

10105

96375

3.12

70.82

22.9

20.9

4.5

e12/l

2.19

9852

93602

(3010813) Leukocytes [#/volume] in Blood

10106

96390

3.12

70.81

22.9

20.9

6.5

6.7

e9/l

13.27

9852

93606

(3000963) Hemoglobin [Mass/volume] in Blood

10105

96395

3.11

70.40

23.0

21.0

136.1

135.6

g/l

3.33

9983

95107

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6217

52748

1.45

69.14

3.0

2.8

—

(3006315) Basophils [#/volume] in Blood

5267

43351

1.44

69.00

6.0

0.0

e9/l

0.09

4535

37204

(40768797) Stomach Pathology biopsy report

1836

12169

1.62

69.00

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8799

80221

1.65

68.95

6.0

5.7

38.7

39.8

mmol/mol

31.81

8139

74379

(3001604) Monocytes [#/volume] in Blood

5248

43171

1.44

68.93

6.0

0.6

e9/l

6.55

4519

37040

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9323

86354

1.81

68.74

5.0

4.4

4.7

mmol/l

0.69

8629

80162

(40761511) CBC panel - Blood by Automated count

9624

90116

1.98

67.47

14.2

13.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9266

85760

1.77

67.29

4.9

4.4

1.5

mmol/l

0.30

8535

79217

(3019198) Lymphocytes [#/volume] in Blood

5360

44414

1.43

66.71

6.0

1.9

e9/l

0.21

4689

38832

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3427

26217

1.46

65.49

2.2

2.1

210.4

209.2

u/l

0.01

3209

24575

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1015

5803

1.83

65.19

2.6

2.3

22.4

25.5

au/ml

0.41

326

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

943

5281

1.86

64.70

1.4

1.3

51.6

51.7

au/ml

0.00

238

(3048689) Calprotectin [Mass/mass] in Stool

1560

10080

1.64

64.53

2.2

2.3

117.0

136.0

ug/g

1.21

1211

7959

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4424

35575

1.43

64.11

2.4

2.2

79.0

77.5

nmol/l

2.69

3976

32084

(40768804) Tissue Pathology biopsy report

4437

35766

1.42

63.09

2.2

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2027

14027

1.55

62.60

1.3

6.8

13.4

u/ml

2.71

738

5438

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5422

45351

1.41

62.01

5.6

6.4

11.4

11.3

umol/l

0.25

5111

43081

(3013650) Neutrophils [#/volume] in Blood by Automated count

5914

50258

1.41

61.49

8.5

9.5

3.9

4.1

e9/l

10.79

5110

43690

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4010

31935

1.42

60.11

3.6

3.4

27.4

68.7

ng/l

1.76

2564

21666

(3007164) IgA [Mass/volume] in Serum or Plasma

2254

16097

1.51

59.78

1.5

2.3

2.5

g/l

5.87

1229

9754

(3019069) Monocytes/100 leukocytes in Blood

4918

40757

1.39

57.59

6.6

6.5

8.6

0.04

4590

38143

(3018010) Neutrophils/100 leukocytes in Blood

4962

41210

1.39

57.22

6.1

6.0

56.3

57.3

7.96

4620

38496

(3002030) Lymphocytes/100 leukocytes in Blood

5019

41821

1.39

56.43

6.4

6.2

28.7

27.8

6.98

4651

38918

(3006504) Eosinophils/100 leukocytes in Blood

4885

40553

1.39

56.01

6.3

6.2

2.9

1.78

4535

37757

(3015377) Calcium [Moles/volume] in Serum or Plasma

3674

29111

1.41

55.38

3.1

3.6

2.4

mmol/l

0.59

3129

25494

(3022096) Basophils/100 leukocytes in Blood

4753

39344

1.39

55.11

6.3

6.2

0.7

2.92

4410

36670

(3013826) Glucose [Moles/volume] in Serum or Plasma

5894

50549

1.39

54.99

4.8

4.7

6.5

6.7

mmol/l

17.07

5557

47240

(42870588) Differential panel, method unspecified - Blood

3721

29576

1.40

54.95

6.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8913

82492

1.58

54.47

13.9

13.3

80.8

81.2

ml/min/173m2

1.01

7455

68197

(3044889) 12 lead EKG panel

6985

61757

1.40

53.50

4.1

3.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8934

82867

1.57

52.54

4.4

4.0

1.3

mmol/l

3.58

8178

75975

(3013139) Helicobacter pylori Ag [Presence] in Stool

955

5761

1.72

50.47

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6541

57535

1.37

49.33

3.2

3.1

44.4

49.6

u/l

5.58

6044

53598

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2513

18922

1.43

49.29

1.7

1.2

mg/l

0.09

1832

14552

(3019309) Folate [Moles/volume] in Red Blood Cells

2090

15207

1.47

49.16

1.7

1099.3

1165.7

nmol/l

2.55

1559

11502

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3391

26933

1.39

48.72

2.6

58.7

57.8

u/l

0.42

3085

24830

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1914

13888

1.46

45.18

1.6

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2249

16871

1.43

44.27

3.8

3.6

297.4

503.6

ng/l

1.75

1687

13090

(3018418) pH of Serum or Plasma

3250

25966

1.37

43.87

3.9

4.1

7.4

0.10

535

4972

(3024561) Albumin [Mass/volume] in Serum or Plasma

4468

37613

1.33

42.07

4.4

5.0

36.4

35.5

g/l

28.97

4107

34983

(3022145) Colonoscopy Study observation

1418

9880

1.50

40.58

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

1642

11822

1.46

39.81

1.4

1.3

583.8

521.3

titre

0.56

321

2487

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2094

15896

1.40

37.61

2.9

3.2

2.4

2.5

mmol/l

8.97

1814

13942

(3021960) Folate [Moles/volume] in Serum or Plasma

2484

19476

1.36

36.39

1.6

1.5

21.9

20.3

nmol/l

3.17

2125

16700

(3035350) Ketones [Presence] in Urine by Test strip

4857

41905

1.30

36.17

3.8

3.6

0.0

estimate

1.34

813

7704

(3011397) Hemoglobin [Presence] in Urine by Test strip

2547

20100

1.35

35.65

3.8

3.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

8471

79050

1.40

35.59

17.0

15.4

40.0

39.9

0.23

6085

57395

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2911

23454

1.34

35.43

1.7

1.6

1.3

1.4

mmol/l

2.86

2472

19674

(3013512) EKG study

3029

24601

1.33

34.73

4.0

3.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

4860

42084

1.29

34.58

5.1

4.8

0.0

estimate

1.08

836

7851

(3018095) Leukocytes [#/volume] in Urine

3678

30719

1.31

34.37

3.8

3.6

60.1

98.5

e6/l

4.89

2555

21670

(3009261) Glucose [Presence] in Urine by Test strip

4896

42533

1.29

33.57

3.9

3.6

0.0

estimate

0.72

815

7654

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3288

27282

1.30

31.55

5.3

4.8

2.0

2.9

ug/l

5.12

2976

24576

(36660697) Celiac disease serology panel - Serum

972

6589

1.52

31.22

1.2

—

(3000494) Fungus identified in Specimen by Culture

1382

10115

1.42

29.92

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1943

15068

1.36

29.65

2.7

2.8

0.9

1.3

e6/l

1.41

1086

8543

(3030467) Casts [#/volume] in Urine by Automated count

2947

24287

1.30

29.26

3.2

3.1

0.3

0.4

e6/l

3.70

2169

18163

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

668

4224

1.62

29.01

1.1

—

(36304419) Bacteria [Presence] in Urine

2871

23660

1.30

28.31

3.2

3.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2563

20825

1.31

28.07

2.3

2.2

2.8

2.9

mg/l

3.03

2173

17846

(3017446) Testosterone [Moles/volume] in Serum or Plasma

900

6189

1.50

26.85

2.3

2.1

13.4

12.7

nmol/l

1.94

794

5467

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2878

23860

1.29

26.78

2.7

2.9

1055.5

1300.6

ng/l

1.47

2402

20527

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1086

7785

1.44

26.15

2.3

365.9

373.7

nmol/l

0.68

973

7165

(3019225) pH of Specimen

1149

8339

1.43

25.83

3.7

4.3

—

(3002582) Erythrocytes [#/volume] in Urine

3134

26361

1.27

25.71

3.3

3.2

103.0

82.5

e6/l

0.25

2361

20123

(3003327) Ova and parasites identified in Stool by Light microscopy

467

2783

1.71

25.47

1.8

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

757

5085

1.53

25.21

1.4

1.3

172.0

253.1

u/ml

2.50

689

4684

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2638

21788

1.28

24.94

4.5

4.1

21.8

0.00

1216

10554

(3015171) Extractable nuclear Ab [Units/volume] in Serum

545

3414

1.63

24.55

1.3

1.2

0.3

0.9

u/ml

1.95

295

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

794

5424

1.50

24.40

3.1

3.3

4.5

4.4

pmol/l

0.44

694

4819

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1778

13993

1.33

23.97

2.9

2.4

2.6

e6/l

0.16

925

7517

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1368

10426

1.36

22.78

4.9

4.5

32.8

32.3

1.16

946

7049

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

393

2315

1.73

22.38

1.8

1.7

40.7

41.5

nmol/l

0.26

383

2244

(3026493) Urate [Moles/volume] in Serum or Plasma

2765

23264

1.26

21.85

2.6

3551.6

4348.3

umol/l

0.53

2352

20196

(3032080) INR in Blood by Coagulation assay

3976

34852

1.23

21.50

8.6

1.2

inr

0.89

1058

9917

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

501

3177

1.61

21.47

1.7

1.6

—

(4010399)

881

6303

1.43

21.28

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1371

10617

1.34

20.38

7.0

6.7

—

(3002385) Erythrocyte distribution width [Ratio]

7680

72219

1.25

20.19

18.4

17.4

13.6

13.7

4.37

7535

70731

(3000850) Epithelial cells [#/volume] in Urine

2204

18211

1.27

20.02

2.5

2.6

4.0

5.6

e6/l

11.57

1893

15894

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

652

4459

1.49

19.87

2.4

—

(40768443) Skin Pathology biopsy report

583

3904

1.52

19.65

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

518

3391

1.56

19.36

1.1

1.3

7.4

u/ml

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

296

1683

1.78

19.12

1.9

198.8

199.7

pmol/l

0.05

277

1579

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1651

13232

1.29

19.04

1.5

1.4

—

(40758558) Short blood count panel - Blood

2650

22484

1.24

18.90

6.4

7.1

—

(3008898) HLA-B27 [Presence]

436

2760

1.61

18.83

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1114

8469

1.35

18.64

2.5

35.3

44.7

u/l

0.92

938

7262

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1943

15974

1.27

18.18

3.1

2.9

0.7

ug/l

2.68

1338

10616

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

230

1241

1.87

17.64

1.3

0.6

2.7

nmol/l

1.02

223

1200

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

769

5559

1.41

17.46

1.3

1.2

133.2

147.2

iu/ml

0.50

302

2084

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1656

13418

1.28

17.38

1.9

2.1

29.2

29.8

4.47

1609

13030

(3021589) Normoblasts [#/volume] in Blood

4309

38632

1.20

17.14

9.6

9.7

0.0

e9/l

0.40

3441

31526

(3000492) Spirometry study

1087

8341

1.34

17.03

1.5

—

(3026008) Bacteria identified in Urine by Culture

2936

25406

1.22

16.94

3.2

3.0

—

(3003338) MCHC [Mass/volume]

7804

73930

1.23

16.93

20.0

18.2

332.8

332.3

g/l

4.92

7765

73424

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

228

1248

1.85

16.74

1.4

1.3

0.2

nmol/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

385

2441

1.60

16.55

1.3

43.5

39.6

u/ml

0.08

140

(42529406) Shigella sp [Presence] in Stool by Culture

391

2497

1.59

16.31

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

390

2490

1.59

16.29

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

2668

22945

1.22

16.25

3.9

4.0

91.7

90.5

1.66

2605

22371

(3026782) Osmolality of Urine

2009

16785

1.24

16.09

2.7

538.7

546.2

mosm/kgh2o

0.76

1646

14287

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

385

2470

1.58

15.76

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1290

10254

1.29

15.61

2.6

2.8

7.7

8.7

umol/l

0.83

1100

8908

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

950

7247

1.34

15.44

2.4

2.3

5.6

7.6

ug/l

4.12

801

6376

(3020961) Endomysium IgA Ab [Titer] in Serum

537

3726

1.47

15.22

1.1

735.0

223.8

titre

—

100

(3025941) Bacteria identified in Stool by Culture

654

4744

1.40

14.54

1.3

—

(4094501)

372

2418

1.56

14.41

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

204

1135

1.81

14.28

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1234

9874

1.28

14.11

1.7

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

294

1822

1.63

13.93

1.3

1.2

23.8

51.4

u/ml

3.06

182

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

863

6589

1.34

13.91

2.0

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

552

3930

1.43

13.65

2.0

1.9

—

(3049717) Cytology report of Urine Cyto stain

463

3201

1.47

13.39

2.5

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2439

21124

1.20

13.34

2.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

325

2094

1.57

13.12

1.2

1.3

521.5

524.8

mg/l

0.04

312

1995

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

939

7320

1.31

13.06

2.1

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1605

13414

1.23

12.49

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1721

14517

1.22

12.23

3.1

3.4

0.8

mmol/l

3.22

1576

13598

(1002224) Polysomnography panel

497

3547

1.42

12.15

1.1

—

(3019150) Specific gravity of Urine by Refractometry

2101

18083

1.20

12.12

4.3

4.0

1.0

kg/l

0.66

301

2777

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

323

2118

1.54

12.09

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

288

1843

1.58

12.01

1.2

1.3

3.6

3.8

mmol/l

1.87

271

1743

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

385

2631

1.48

11.85

1.9

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3213

28753

1.17

11.69

3.3

30.6

35.3

u/l

3.95

3026

27214

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

338

2257

1.51

11.65

1.4

1.3

6.5

6.3

u/ml

0.03

349

(3009214) Lutropin [Units/volume] in Serum or Plasma

314

2064

1.54

11.64

1.4

9.8

10.7

u/l

0.46

253

1704

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

354

2388

1.50

11.62

1.5

1.4

10.1

16.0

iu/ml

0.60

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

439

3099

1.44

11.42

1.9

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

268

1708

1.58

11.39

1.2

1.4

—

(40761535) Cells panel - Urine sediment

873

6874

1.29

11.24

3.7

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4452

40934

1.15

11.15

3.9

4.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

899

7117

1.29

11.11

2.4

2.6

67.9

66.2

ml/min/173m2

0.68

371

2731

(3004716) Salmonella sp identified in Stool by Organism specific culture

556

4113

1.37

11.02

1.3

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

331

2228

1.50

11.00

1.3

4.4

4.1

u/ml

0.06

227

(3000570) Elastase.pancreatic [Mass/mass] in Stool

375

2597

1.46

10.81

1.4

282.2

272.8

ug/g

0.38

208

1517

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

901

7162

1.28

10.78

2.6

2.7

132.8

189.7

ng/l

7.39

829

6499

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

820

6447

1.30

10.68

3.5

3.9

83.9

90.9

ng/l

1.67

705

5589

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

331

2256

1.48

10.37

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

3076

27678

1.16

10.08

2.3

2.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

505

3737

1.37

10.01

1.4

1.6

14.7

16.9

u/ml

—

(3005719) IgG [Mass/volume] in Serum or Plasma

820

6508

1.28

9.93

3.1

2.7

10.4

10.5

g/l

0.51

743

5977

(46235355) HIV 1 and 2 tests - Meaningful Use set

1579

13460

1.20

9.91

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

197

1210

1.64

9.81

1.4

—

(3002256) Pathology report gross observation

1374

11582

1.21

9.67

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1570

13421

1.20

9.53

2.3

2.5

14.1

13.0

umol/l

6.28

1427

12460

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3530

32215

1.15

9.30

4.1

3.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

273

1836

1.50

9.18

1.3

1.2

7.5

2.6

u/ml

0.51

137

(3022217) INR in Platelet poor plasma by Coagulation assay

1317

11143

1.21

8.89

24.7

23.4

1.3

inr

0.04

198

1624

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1455

12426

1.20

8.89

2.3

2.5

2.3

g/l

0.41

1313

11548

(3017732) Neutrophils [#/volume] in Blood

751

5981

1.28

8.85

2.6

3.0

3.9

4.1

e9/l

1.73

549

4674

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

113

615

1.85

8.68

1.4

1.3

72.7

118.1

pmol/l

0.43

187

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

365

2624

1.41

8.66

1.8

1.6

1.2

g/l

1.74

349

2490

(3023323) Follitropin [Units/volume] in Serum or Plasma

458

3418

1.36

8.64

1.4

1.3

31.4

31.7

iu/l

0.05

398

2951

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

493

3722

1.34

8.62

2.1

1.9

38.3

39.3

u/l

0.57

435

3285

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

149

882

1.70

8.60

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

354

2540

1.41

8.50

1.8

1.6

0.2

g/l

0.76

339

2404

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

412

3033

1.37

8.48

1.5

1.7

3.6

3.5

mg/l

0.08

283

2147

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1362

11645

1.20

8.19

2.4

2.6

23.8

22.5

2.54

1151

9977

(40760892) CBC W Ordered Manual Differential panel - Blood

2134

18937

1.16

8.14

4.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

160

980

1.64

8.14

2.3

2.1

28.2

24.9

mg/l

0.26

274

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2032

17981

1.16

8.04

1.7

39088585.1

29938312.7

pmol/l

0.27

1645

14971

(3021387) Prolactin [Units/volume] in Serum or Plasma

334

2404

1.40

7.90

1.6

1.7

274.2

300.3

mu/l

0.72

303

2185

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1101

9263

1.21

7.86

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

150

913

1.65

7.84

1.2

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

629

4985

1.28

7.73

1.6

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

113

639

1.78

7.71

1.2

35.4

42.1

mg/l

0.88

100

539

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1135

9599

1.20

7.66

1.7

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

267

1858

1.45

7.63

1.3

1.4

638.8

1145.4

e6/l

0.71

214

1499

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

106

593

1.80

7.51

1.1

—

(3045414) Leukocytes [Presence] in Urine

501

3872

1.31

7.48

1.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

109

616

1.78

7.47

1.1

234.1

277.3

mg/l

1.99

102

541

(44813793)

101

561

1.81

7.34

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1095

9296

1.20

7.09

1.8

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

171

1104

1.56

7.05

1.3

65.6

56.0

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

299

2156

1.40

7.05

1.1

3.9

7.7

u/ml

1.12

265

(3028026) IgM [Mass/volume] in Serum or Plasma

628

5039

1.26

6.99

2.2

1.9

1.4

g/l

0.02

570

4598

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

263

1858

1.43

6.97

1.3

1.4

61.6

22.8

e6/l

0.37

194

1425

(3052851) Hemolysis interference index of Serum or Plasma

361

2695

1.35

6.87

3.1

3.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

129

790

1.64

6.65

1.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

524

0.27

6.64

20.6

17.5

1512.5

3268.6

nmol/l

0.48

506

(3024980) IgG subclass 4 [Mass/volume] in Serum

207

1416

1.47

6.53

1.7

1.6

0.7

0.8

g/l

0.44

150

1071

(3011985) Renin [Units/volume] in Plasma

179

1190

1.51

6.50

1.5

1.4

100.9

58.6

mu/l

1.06

157

1073

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

321

2376

1.36

6.48

2.2

2.0

10.1

11.2

mg/l

1.76

295

2222

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

510

1.79

6.47

1.2

1.1

1.3

10.8

nmol/l

1.95

100

(3029937) Albumin [Presence] in Urine by Test strip

2467

22434

1.13

6.37

4.4

4.0

0.0

estimate

2.76

814

7593

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

455

1.83

6.35

1.1

u/l

0.06

211

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

510

0.27

6.35

12.9

11.9

700.8

865.6

nmol/l

1.78

487

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1319

11485

1.17

6.34

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

747

6179

1.23

6.33

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

168

1118

1.51

6.10

1.4

1.3

257.4

311.4

pmol/l

0.90

135

852

(3033923) Metanephrine [Moles/time] in 24 hour Urine

182

2.31

6.06

1.1

0.6

0.7

umol/24h

1.26

(3017143) Hepatitis C virus Ab [Presence] in Serum

1092

9403

1.18

6.01

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

410

3182

1.30

6.00

2.3

2.9

3.1

g/l

3.33

324

2518

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

179

1215

1.48

5.92

1.1

11.4

12.3

au/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

724

6020

1.22

5.85

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1135

9836

1.17

5.78

4.1

4.4

240.8

244.4

u/l

0.38

1061

9302

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

381

2948

1.30

5.72

1.5

1.6

206.2

291.7

titre

0.36

119

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

547

1.71

5.65

1.5

1.3

1.6

1.9

u/ml

0.12

240

(3020630) Protein [Mass/volume] in Serum or Plasma

845

7160

1.20

5.60

2.8

2.6

66.6

g/l

0.04

772

6540

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

102

617

1.66

5.59

2.2

3.5

99.8

151.2

nmol/l

1.06

102

611

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

215

2.14

5.57

1.3

94.6

136.9

nmol/l

1.19

155

(3010726) Horse dander IgE Ab [Units/volume] in Serum

171

1168

1.47

5.51

1.1

2.1

1.8

u/ml

0.08

275

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

432

3417

1.28

5.49

1.9

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

156

1050

1.49

5.41

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

373

2903

1.30

5.39

2.7

2.3

0.7

0.8

g/l

0.33

327

2511

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

102

625

1.64

5.34

1.2

1.3

1.9

2.1

mmol/l

1.94

593

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

565

1.67

5.30

1.4

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

286

2152

1.34

5.27

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

423

3361

1.27

5.20

2.3

2.2

7.2

7.4

g/l

2.28

331

2579

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

592

1.64

5.17

1.8

2.0

18.6

17.6

nmol/l

0.60

554

(3004588) Protein electrophoresis panel - Serum or Plasma

701

5886

1.20

5.15

2.4

2.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

369

1.82

5.13

1.1

5.9

8.2

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

421

3350

1.27

5.12

2.3

2.2

3.7

3.9

g/l

1.76

312

2467

(3006270) Folate [Moles/volume] in Blood

110

696

1.59

5.08

1.2

1.1

340.9

370.2

nmol/l

0.91

101

596

(3003888) Timothy IgE Ab [Units/volume] in Serum

183

1289

1.43

5.05

1.1

6.3

4.8

u/ml

0.41

628

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

421

3356

1.27

5.05

2.3

2.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

157

1075

1.47

5.03

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

199

1426

1.40

4.99

1.2

1.1

0.9

1.3

u/ml

0.53

551

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

560

1.65

4.97

1.4

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

395

3138

1.27

4.88

1.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

412

1.75

4.88

1.4

1.6

7.9

8.4

ug/l

0.14

364

(3021879) Hepatitis B virus core Ab [Presence] in Serum

728

6170

1.19

4.84

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

333

2594

1.29

4.82

2.3

2.2

0.0

g/l

1.68

307

2366

(3008401) Mugwort IgE Ab [Units/volume] in Serum

175

1239

1.42

4.72

1.1

0.7

1.3

u/ml

1.25

499

(3023410) Appearance of Cerebral spinal fluid

129

863

1.50

4.67

1.4

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

130

872

1.50

4.65

3.3

3.5

58.8

57.2

0.29

558

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

3138

1.26

4.57

2.3

9.8

10.3

g/l

1.72

332

2662

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

396

3181

1.25

4.49

3.6

3.7

25.0

24.9

mmol/l

0.36

360

2934

(4027681)

484

1.66

4.47

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

338

2668

1.28

4.44

2.2

38.5

37.7

g/l

1.88

294

2320

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

331

2606

1.28

4.44

1.6

0.5

9.4

iu/ml

0.83

579

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

239

1804

1.33

4.38

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

239

1804

1.33

4.38

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

196

2.04

4.37

1.2

—

(4062490)

127

863

1.48

4.30

1.5

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

355

2832

1.26

4.29

1.4

1.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.53

4.28

1.0

1.2

0.2

2.7

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

533

1.60

4.15

1.5

4.9

6.4

u/l

2.21

462

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

133

919

1.45

4.15

1.7

1.8

4177.8

1134.7

titre

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

126

1811

0.69

4.11

3.2

3.4

23.0

27.6

mg/l

0.77

1128

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

122

834

1.47

4.03

1.8

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

812

7057

1.16

4.03

2.7

2.6

71.2

70.9

e9/l

0.07

601

5252

(3012494) Peanut IgE Ab [Units/volume] in Serum

182

2.04

4.02

1.1

0.7

1.9

u/ml

0.69

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

162

1170

1.39

3.97

1.1

—

(3044941) Cell count panel - Synovial fluid

186

1377

1.36

3.92

1.5

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

342

1.73

3.90

1.5

1.2

4.3

4.2

umol/l

0.02

317

(3023420) DNA double strand Ab [Units/volume] in Serum

135

949

1.43

3.87

1.6

1.5

51.2

24.2

iu/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

302

2397

1.27

3.85

2.3

0.0

g/l

0.00

279

2202

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

271

2126

1.28

3.80

2.1

1.8

61.6

8.5

iu/l

0.45

771

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

338

1.72

3.78

1.0

1.1

1607.3

651.1

ng/l

0.46

(3027945) Reticulocytes/100 erythrocytes in Blood

1058

9417

1.14

3.76

2.3

2.5

1.8

0.24

918

8367

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

602

5139

1.18

3.75

3.3

3.5

5.1

kpa

0.60

540

4766

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

305

2433

1.26

3.74

2.3

2.2

0.0

g/l

0.63

280

2210

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

393

1.66

3.71

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.45

3.70

1.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

869

7657

1.15

3.60

7.3

1.3

mmol/l

1.41

845

7393

(3047007) Chlamydophila sp Ab [Presence] in Serum

155

1132

1.37

3.59

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

138

990

1.40

3.56

1.2

1.3

—

29.7

—

(3009343) pH of Capillary blood

593

5080

1.18

3.56

3.3

3.5

7.4

0.73

671

(40761536) Microorganisms panel - Urine sediment

820

7202

1.15

3.56

4.2

3.9

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

123

865

1.43

3.55

1.4

1.3

0.4

g/l

1.12

597

(3000475) Leukocytes [#/volume] in Synovial fluid

270

2137

1.27

3.55

1.6

9463.6

13563.8

e6/l

0.97

203

1522

(3028192) IgG subclass 2 [Mass/volume] in Serum

123

866

1.43

3.53

1.4

1.3

2.8

3.0

g/l

0.45

598

(3009508) Creatinine [Moles/volume] in Urine

2921

27497

1.09

3.53

3.2

7.6

7.5

mmol/l

0.34

2429

23123

(3023368) Bacteria identified in Blood by Culture

2460

22992

1.09

3.51

4.1

4.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

549

1.53

3.49

2.9

2.8

0.2

e9/l

0.28

472

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

155

1138

1.37

3.49

1.4

25.9

30.0

u/l

0.78

122

929

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

289

2313

1.26

3.47

1.4

1.3

244.7

217.4

miu/ml

0.63

136

1023

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

115

804

1.44

3.44

5.0

47.8

86.9

u/ml

0.85

228

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1243

11248

1.12

3.38

5.1

6.0

1.0

mmol/l

3.90

1141

10497

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

202

1.88

3.37

1.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

122

866

1.41

3.37

1.4

1.3

6.4

6.8

g/l

0.66

597

(3008757) Leukocyte morphology finding [Identifier] in Blood

127

908

1.40

3.37

3.8

4.0

—

(3022621) pH of Urine by Test strip

649

5630

1.16

3.35

3.1

2.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

453

1.57

3.30

2.1

3.2

20.1

28.4

mu/l

1.10

433

(3014051) Protein [Presence] in Urine by Test strip

256

2033

1.27

3.30

2.3

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

488

1.54

3.21

1.1

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

345

2842

1.22

3.21

2.6

2.7

—

(3039000) Anion gap in Blood

241

1908

1.27

3.20

7.8

7.3

11.1

11.2

mmol/l

0.31

229

1697

(3018572) Chloride [Moles/volume] in Blood

241

1909

1.27

3.19

7.8

7.3

104.9

105.2

mmol/l

0.39

229

1698

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

684

1.45

3.18

1.3

1.2

27.2

35.0

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

164

1.95

3.18

1.1

—

(3003396) Base excess in Arterial blood by calculation

1105

9970

1.12

3.17

7.7

7.5

0.9

1.0

mmol/l

0.65

897

7866

(3045424) Erythrocytes [Presence] in Urine

183

1400

1.31

3.17

1.4

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.73

3.15

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

200

1.85

3.14

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

291

2364

1.24

3.10

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.80

3.08

1.1

1.2

—

2.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1106

9998

1.12

3.07

7.7

7.5

5.0

5.1

kpa

2.53

1069

9541

(3027801) Oxygen [Partial pressure] in Arterial blood

1105

9993

1.12

3.05

7.7

7.5

13.0

12.5

kpa

2.62

1062

9529

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

569

1.48

3.01

6.2

6.3

—

(3022313) Gas panel - Capillary blood

433

3670

1.19

3.00

3.4

3.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

4.29

2.99

1.2

1.0

—

(3047181) Lactate [Moles/volume] in Blood

324

2674

1.22

2.98

6.9

6.3

1.2

1.3

mmol/l

1.01

298

2342

(3021788) Differential panel - Synovial fluid

211

1662

1.28

2.95

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

137

1018

1.35

2.92

1.1

1.9

3.7

u/ml

1.36

386

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

450

3837

1.18

2.92

1.6

1.7

1.5

1.6

g/l

0.24

385

3294

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

144

1079

1.34

2.91

2.6

3.4

5.2

11.8

nmol/l

0.67

137

1051

(3014271) Vancomycin [Susceptibility]

365

1.59

2.90

3.1

2.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

508

4378

1.17

2.89

2.3

2.7

0.2

0.3

e6/l

2.74

485

4267

(3020874) Milk IgE Ab [Units/volume] in Serum

421

1.55

2.88

1.1

1.0

0.8

2.0

u/ml

0.52

114

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

575

1.46

2.87

2.9

2.7

509.8

509.2

e6/l

0.00

476

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

100

708

1.42

2.86

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

554

4815

1.16

2.83

10.2

9.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

128

947

1.36

2.82

1.1

6.5

3.3

u/ml

0.65

365

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

562

4896

1.16

2.79

3.3

3.4

1.5

1.8

mmol/l

1.64

420

3678

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

111

805

1.38

2.78

4.3

3.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

654

1.43

2.77

1.2

5.6

u/ml

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.26

2.76

1.1

1.2

1.7

umol/24h

0.02

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.17

2.76

1.5

1.3

0.3

nmol/l

0.04

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

181

1413

1.29

2.75

1.9

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

553

4824

1.15

2.71

1.4

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

256

1.68

2.69

1.1

1.3

25.8

24.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

286

2359

1.22

2.69

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2388

22530

1.08

2.64

3.4

3.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

116

856

1.36

2.63

1.1

1.0

0.1

0.7

u/ml

1.19

191

(3012516) Albumin [Mass/volume] in Urine

2748

26065

1.07

2.62

3.2

559.9

416.6

mg/l

0.62

1605

16393

(3035320) C reactive protein [Mass/volume] in Body fluid

645

1.41

2.62

3.1

2.5

—

(3051611) Lipemic interference index of Serum or Plasma

126

943

1.34

2.61

3.3

3.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

604

1.43

2.60

1.9

1.8

—

(3023419) Bacteria identified in Sputum by Culture

141

1073

1.32

2.60

3.6

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

104

756

1.38

2.59

1.8

1.9

7.2

6.6

umol/l

0.07

555

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

140

1066

1.32

2.58

1.4

0.3

0.4

nmol/l

0.27

111

785

(3028433) Virus identified in Specimen by Culture

298

1.61

2.58

1.3

1.2

—

(4034850)

325

2731

1.20

2.54

9.5

9.4

—

(3036489) Thrombin time

386

3294

1.18

2.53

1.8

2.1

21.3

21.6

0.42

335

2867

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

403

1.52

2.52

1.1

1.3

55.8

67.4

—

(21494434) Karyotype in Bone marrow

100

730

1.37

2.45

1.1

1.2

—

(3011412) CD3 cells [#/volume] in Blood

111

824

1.35

2.45

2.7

2.5

1.3

1.2

e9/l

0.66

497

(21494755) Public health laboratory ask at order entry panel

716

7987

0.89

2.42

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

117

877

1.34

2.42

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

280

1.61

2.41

2.1

1.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.29

2.40

1.7

2.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

139

1.87

2.35

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

162

1.79

2.30

2.9

2.7

127.7

137.7

ng/l

0.06

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

207

1.69

2.29

1.2

219.8

325.6

pmol/l

1.43

150

(3007566) Smooth muscle Ab [Titer] in Serum

291

2449

1.19

2.27

1.2

1.3

120.0

148.6

titre

0.20

230

(3002173) Hemoglobin [Mass/volume] in Arterial blood

907

8256

1.11

2.27

8.5

8.3

122.3

121.3

g/l

0.91

886

7946

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

638

1.38

2.27

2.2

2.1

13.4

14.4

0.28

274

(3020682) Albumin/Creatinine [Ratio] in Urine

2866

27344

1.07

2.27

3.9

4.0

7.1

9.2

mg/mmol

2.14

1642

17181

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

317

1.55

2.26

1.5

1.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.89

2.25

1.7

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

538

4753

1.14

2.25

9.3

9.5

24.2

24.3

mmol/l

0.49

507

4456

(3011288) Drugs identified in Urine by Screen method

205

1669

1.23

2.25

3.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

204

1660

1.23

2.25

1.7

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

1138

0.73

2.23

1.6

1.4

33.2

g/l

0.01

1023

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

230

1901

1.21

2.19

1.4

—

(3016502) Oxygen saturation in Arterial blood

973

8908

1.10

2.18

8.2

7.9

96.3

95.7

3.11

946

8574

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

377

1.49

2.16

1.6

2.0

139.6

151.2

0.43

357

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

122

1.89

2.15

1.7

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

435

1.45

2.15

1.5

1.6

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.16

2.14

1.8

2.1

20.5

19.5

mg/l

0.11

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

469

1.43

2.13

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

172

2127

0.81

2.13

2.4

76.7

90.6

ug/min

0.29

1285

(3042936) Bacteria identified in Isolate by Culture

1314

12213

1.09

2.12

2.0

2.1

—

(3008295) Osmolality of Serum or Plasma

113

863

1.31

2.11

1.5

1.3

275.0

278.8

mosm/kgh2o

0.91

669

(3038177) Helicobacter pylori Ab [Presence] in Serum

174

1403

1.24

2.10

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

404

1.46

2.10

1.4

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.21

2.10

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

666

1.35

2.08

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

666

1.35

2.08

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

397

3456

1.15

2.08

6.1

5.3

1.6

1.7

0.25

378

3218

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

117

900

1.30

2.07

1.8

1.7

—

(4024509)

107

813

1.32

2.07

1.7

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

324

1.51

2.07

1.8

1.6

2.0

1.9

umol/l

0.35

300

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.26

2.07

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

406

1.46

2.06

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

218

1805

1.21

2.06

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1180

10933

1.09

2.05

7.3

7.4

104.6

104.4

mmol/l

0.94

1167

10707

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

668

1.35

2.04

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

254

1.58

2.02

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

383

1.46

2.02

1.1

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

118

1.87

2.01

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

789

7183

1.11

2.00

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

247

1.58

2.00

1.0

1.2

86.9

90.1

0.18

117

(3037121) Protein [Mass/volume] in Urine

334

2882

1.16

1.98

3.2

0.2

0.3

g/l

1.03

132

1243

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

171

1388

1.24

1.97

1.3

33.4

34.1

u/l

0.02

146

1211

(3002179) Metamyelocytes/100 leukocytes in Blood

744

6759

1.11

1.97

3.8

3.9

0.7

0.07

173

1528

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

264

1.56

1.96

3.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

310

0.52

1.95

1.9

1.8

4135.9

14275.3

e6/l

—

167

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.98

1.94

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

202

1.64

1.94

1.3

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

285

2433

1.18

1.94

1.2

330.0

974.5

titre

—

(3009871) Measles virus Ab [Titer] in Serum

297

1.52

1.94

1.6

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.45

1.92

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

496

1.39

1.92

1.1

11.6

9.7

iu/ml

0.20

117

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

322

1.49

1.92

1.1

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

389

3406

1.15

1.90

6.1

5.4

0.9

2.03

371

3179

(3044242) Glucose [Moles/volume] in Arterial blood

434

0.60

1.89

2.7

1.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

173

1.68

1.89

1.5

2.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

345

0.55

1.88

2.2

2.0

1913.6

809.8

e6/l

0.46

232

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

456

1.41

1.88

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

197

1632

1.21

1.88

2.5

3.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

103

792

1.30

1.87

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

174

1426

1.22

1.85

3.4

1.1

1.5

1.01

127

1095

(3000093) Morphology [Interpretation] in Blood Narrative

103

793

1.30

1.85

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

292

2509

1.17

1.85

2.2

2.5

189.8

194.5

0.39

274

2384

(40759836) Histone Ab [Presence] in Serum by Immunoblot

663

1.33

1.84

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

107

829

1.29

1.84

1.9

1.8

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

261

1.53

1.83

3.7

3.1

8.6

7.8

mg/l

0.32

209

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

664

1.33

1.83

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

664

1.33

1.83

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

318

1.48

1.82

1.5

—

(3019060) Gas panel - Arterial blood

621

5615

1.11

1.82

5.4

5.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

254

1.54

1.80

1.2

40.5

38.4

g/l

0.37

144

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

279

1.51

1.78

1.3

1.2

0.3

g/l

1.23

223

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

187

1552

1.21

1.77

1.2

318.8

284.0

u/ml

0.50

117

1007

(3002523) Influenza virus A Ag [Presence] in Specimen

152

1237

1.23

1.75

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

180

1492

1.21

1.73

1.5

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

152

1239

1.23

1.73

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

105

1335

0.78

1.72

1.1

26.2

7710.9

iu/ml

0.56

315

(3028707) Methadone [Presence] in Urine by Screen method

138

1114

1.24

1.72

2.9

2.8

—

(37021550) Renin [Units/volume] in Plasma --upright

186

1.61

1.71

1.5

1.3

95.3

79.5

mu/l

0.10

142

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

293

2537

1.16

1.71

2.2

2.6

3.5

3.6

g/l

1.34

278

2418

(40768806) Pleura Pathology biopsy report

915

0.74

1.70

1.6

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

171

1.64

1.69

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

133

1.73

1.69

1.4

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

179

1.62

1.69

1.1

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

268

0.52

1.68

2.9

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

268

0.52

1.68

2.9

2.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

111

1.80

1.68

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

316

1.46

1.68

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

211

1.57

1.67

1.0

1.1

—

(3012565) Volume of 24 hour Urine

442

1.38

1.66

2.2

2.1

2393.2

1963.0

1.80

393

(3000991) Gas panel - Venous blood

799

7353

1.09

1.66

8.3

8.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

463

4142

1.12

1.66

4.5

24.2

mmol/l

0.01

412

3737

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

616

1.32

1.63

1.6

1.5

12.7

12.6

umol/l

0.04

583

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

196

1650

1.19

1.62

1.2

—

(3045716) Anion gap in Serum or Plasma

403

0.62

1.62

2.0

2.4

8.1

9.1

mmol/l

0.54

308

(3028308) Erythrocytes [#/volume] in Pleural fluid

930

0.75

1.62

1.6

1.4

66613.4

45195.0

e6/l

0.19

538

(3044007) Cell count panel - Peritoneal fluid

277

0.54

1.61

2.3

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

601

1.32

1.59

3.1

2.8

599.7

659.8

e6/l

0.26

249

(3013293) Extractable nuclear Ab [Presence] in Serum

136

1.69

1.58

1.6

—

(3012441) Differential panel - Pleural fluid

892

0.75

1.58

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

490

1.35

1.57

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

135

1102

1.23

1.55

1.5

—

(3051651) Icteric interference index of Serum or Plasma

535

1.33

1.54

3.7

3.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

158

1312

1.21

1.53

1.2

1.3

3.6

4.0

u/ml

0.34

574

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

161

1340

1.20

1.53

1.2

3.0

3.5

u/ml

0.16

446

(3021440) Promyelocytes/100 leukocytes in Blood

767

7078

1.09

1.52

4.0

4.1

0.1

0.48

218

1951

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

221

1892

1.17

1.52

1.5

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

804

7436

1.09

1.52

3.9

4.1

0.9

0.41

233

2102

(3014599) Egg white IgE Ab [Units/volume] in Serum

416

1.37

1.52

1.1

1.0

2.0

0.8

u/ml

0.46

(3000060) B lymphocytes [#/volume] in Blood

209

1.53

1.50

2.7

2.2

137.1

575.5

e6/l

0.68

108

(3035947) Staphylolysin Ab [Units/volume] in Serum

401

1.37

1.48

1.3

1.1

3.8

4.1

iu/ml

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

441

0.66

1.48

1.5

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

194

1.55

1.47

1.7

1.6

61.3

99.3

au/ml

—

(3003181) Sodium [Moles/volume] in Urine

176

1483

1.19

1.47

1.3

63.4

63.0

mmol/l

0.04

147

1175

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

132

1082

1.22

1.47

1.5

—

(3048879) Bone marrow aspiration report

243

1.48

1.46

1.5

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

610

1.30

1.46

2.2

2.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

134

1102

1.22

1.45

1.1

1.9

3.6

u/ml

1.97

515

(44790047)

115

933

1.24

1.42

1.7

1.5

—

(44790048)

115

933

1.24

1.42

1.7

1.5

—

(44806118)

115

933

1.24

1.42

1.7

1.5

—

(44790049)

115

933

1.24

1.42

1.7

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

110

1.73

1.42

1.4

61.1

59.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

371

1.38

1.40

1.1

1.0

0.4

2.1

u/ml

0.61

(3017704) Immunofixation for Urine

457

1.34

1.40

1.7

—

(40768793) Breast Pathology biopsy report

232

2010

1.16

1.40

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

343

3053

1.13

1.39

2.1

2.3

323.5

555.0

ug/l

1.83

324

2878

(3040151) Glucose [Moles/volume] in Capillary blood

929

0.77

1.39

2.0

13.3

7.1

7.6

mmol/l

0.50

774

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

389

1.36

1.39

6.2

3.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

111

1.71

1.38

1.1

—

(3002032) Base excess in Venous blood by calculation

837

7793

1.08

1.37

3.9

4.0

1.8

2.0

mmol/l

0.69

692

6381

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

408

1.35

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

408

1.35

1.2

1.5

—

(3045788) Cell count panel - Pleural fluid

801

0.76

1.35

1.7

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

131

1085

1.21

1.34

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

182

1553

1.18

1.34

1.2

1.5

121.4

115.3

u/ml

0.24

323

(4268621)

111

904

1.23

1.34

2.2

2.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

159

1.57

1.34

2.2

2.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

170

1443

1.18

1.34

1.4

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

324

1.39

1.33

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

208

1796

1.16

1.33

5.1

5.6

1105.0

2312.1

iu/ml

0.58

269

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

384

1.36

1.32

1.4

1.6

3.0

5.1

nmol/l

0.53

317

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

488

1.31

1.32

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1021

0.79

1.31

1.6

1.5

2957.0

2845.3

e6/l

0.04

721

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

666

1.26

1.29

1.7

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

447

1.32

1.28

1.2

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.48

1.27

1.0

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.29

1.26

1.4

1.1

34.1

37.3

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.29

1.26

1.4

1.1

20.3

21.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.29

1.26

1.1

9.2

8.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.05

1.26

1.3

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

194

1.50

1.26

1.0

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

892

8356

1.07

1.26

2.1

2.3

0.2

g/l

6.82

832

7779

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

178

1.52

1.25

4.6

5.3

53.8

80.0

u/l

0.46

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

475

1.31

1.25

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

141

1186

1.19

1.25

1.0

1.1

1.5

g/l

0.01

126

1073

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.74

1.24

1.5

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.74

1.24

2.6

2.1

—

(3010503) CD19 cells [#/volume] in Blood

537

1.29

1.24

2.8

2.7

1.2

0.3

e9/l

0.39

516

(40758358) Immune stain study

2.22

1.24

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

156

1327

1.18

1.22

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.63

1.21

1.2

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

254

2243

1.14

1.21

1.2

1.3

—

(3016879) Cocaine [Presence] in Urine

263

2329

1.13

1.20

2.4

2.2

—

(3024869) Neuronal Ab [Presence] in Serum

172

1.51

1.20

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

710

1.24

1.19

1.4

1.2

171.7

186.6

titre

0.07

134

(3026470) Cobalt [Mass/volume] in Blood

577

1.27

1.18

2.3

2.0

3.1

3.4

ug/l

0.17

503

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

173

1.50

1.17

7.9

5.8

75.2

72.1

0.42

141

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

133

1.58

1.17

1.3

45.7

148.5

ng/l

1.09

(44816559) Phosphatidylethanol [Mass/volume] in Blood

182

1575

1.16

1.1

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

291

2599

1.12

1.16

1.4

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

288

2571

1.12

1.16

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

832

7802

1.07

1.16

3.9

4.0

5.8

kpa

0.51

802

7581

(21491868) Cryoglobulin [Mass/volume] in Serum

325

1.36

1.15

1.2

—

0.2

g/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

128

1078

1.19

1.14

1.6

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

150

1.53

1.14

1.1

43.4

61.1

u/ml

0.95

145

(3025130) Human papilloma virus identified in Specimen

129

1088

1.19

1.13

1.6

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

1079

1.19

1.13

1.6

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

326

1.35

1.13

1.1

—

(3027944) Amphetamines [Presence] in Urine

278

2482

1.12

1.13

2.4

2.1

—

(3025577) Chromium [Mass/volume] in Blood

563

1.26

1.13

2.3

2.0

1.9

2.4

ug/l

0.75

467

(3024354) Oxygen [Partial pressure] in Venous blood

679

6328

1.08

1.12

3.3

4.5

4.6

kpa

0.48

653

6117

(3019230) Fractional oxyhemoglobin in Venous blood

175

1515

1.16

1.12

4.1

3.3

64.2

64.4

0.03

175

1509

(3025159) Blasts/100 leukocytes in Blood

715

6677

1.08

1.12

4.0

4.1

0.3

0.2

0.10

179

1639

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.90

1.12

1.2

—

(4133840)

226

1.42

1.09

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.38

1.09

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.38

1.09

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

243

2158

1.13

1.09

2.7

2.1

3743.1

4715.5

u/l

0.24

847

(3025468) Yersinia sp identified in Specimen by Organism specific culture

127

1075

1.18

1.08

1.6

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

710

1.23

1.08

1.4

1.2

140.0

155.7

titre

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

130

1103

1.18

1.08

1.5

1.6

58.5

57.3

0.14

690

(3028300) Cannabinoids [Presence] in Urine

282

2530

1.12

1.07

2.4

2.1

—

(3035880) pH of Pleural fluid

455

0.72

1.06

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

120

1013

1.19

1.06

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

236

1.40

1.06

1.3

1.6

8.6

9.0

ug/l

0.19

236

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

489

1.27

1.05

2.6

2.8

42.6

37.9

1.05

170

(1001926) Buprenorphine [Presence] in Urine by Screen method

219

1938

1.13

1.04

2.7

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

220

1949

1.13

1.03

1.7

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.27

1.03

1.0

0.2

g/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.96

1.03

1.0

—

(4306422)

153

1322

1.16

1.03

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

255

1.37

1.02

1.0

1.1

88.1

89.1

0.10

116

(21494814) CD8 cells/100 lymphocytes in Specimen

350

1.32

1.02

2.1

2.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

394

1.30

1.01

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

106

0.47

1.00

1.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.88

1.00

1.8

1.4

394.7

324.6

umol/24h

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

1178

1.17

0.99

1.5

—

(3027008) Opiates [Presence] in Urine

280

2524

1.11

0.99

1.6

2.0

—

(3024928) Oxygen saturation in Venous blood

209

1852

1.13

0.99

4.2

3.6

—

(3033799) Differential panel - Peritoneal fluid

309

0.68

0.99

1.6

1.9

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.84

0.98

2.8

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

198

1750

1.13

0.98

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

353

1.30

0.97

3.4

5.2

63.8

1291.9

mg/l

0.82

259

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

301

1.33

0.96

7.3

2.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

131

1126

1.17

0.96

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

822

1.19

0.96

2.4

3.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

157

1370

1.15

0.95

1.6

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

568

5301

1.08

0.95

7.7

7.3

24.8

24.6

mmol/l

0.63

545

4914

(3030313) Adrenal Ab [Titer] in Serum

1.77

0.94

1.1

—

(40765096) Chromosome analysis panel by Banding

242

1.36

0.94

1.1

—

(40768441) Liver Pathology biopsy report

680

0.79

0.94

1.6

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.65

0.94

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1085

10341

1.05

0.93

1.6

1.8

1.4

1.5

1.79

933

9013

(3051593) INR in Capillary blood by Coagulation assay

364

1.29

0.93

5.1

11.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

225

2013

1.12

0.93

1.7

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

142

0.56

0.93

1.5

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

142

0.56

0.93

1.5

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

142

0.56

0.93

1.5

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

798

1.19

0.92

1.5

1.6

32.5

31.4

0.09

475

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.72

0.92

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.73

0.92

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.73

0.92

9.3

4.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

124

1066

1.17

0.92

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.14

0.91

1.2

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

301

2739

1.10

0.91

2.0

2.2

92.6

91.3

0.46

279

2552

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

499

4643

1.08

0.91

3.1

3.7

62.0

59.5

u/ml

0.03

481

4470

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

184

1.41

0.91

1.1

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

194

1724

1.13

0.90

1.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

545

1.23

0.90

1.1

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

510

1.24

0.89

1.4

1.3

42.9

69.5

titre

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

135

1.48

0.88

1.3

1.8

22.8

54.0

pmol/l

2.09

118

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

130

1127

1.16

0.88

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

168

1899

0.88

0.87

2.7

3.6

376.3

636.6

u/ml

0.39

144

1734

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.61

0.87

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

593

1.22

0.87

1.0

301.1

337.4

ng/l

0.57

425

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

593

1.22

0.87

1.0

805.5

723.3

ng/l

0.80

412

(3045142) Bone marrow Pathology biopsy report

115

989

1.16

0.86

1.2

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

229

1.35

0.86

3.3

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

212

1.37

0.86

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

361

1.28

0.85

1.1

—

(3016228) CD19 cells/100 cells in Blood

361

1.28

0.85

2.1

2.0

9.4

8.6

0.12

350

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.59

0.84

1.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

724

1.19

0.84

2.5

2.3

42.1

41.5

0.05

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

596

1.21

0.84

1.0

66.9

43.0

ng/l

0.43

417

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

205

1.37

0.83

1.4

1.5

0.5

0.4

ug/l

0.90

131

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

171

1.40

0.82

1.1

1.2

112.6

109.5

0.20

164

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.74

0.82

1.0

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.88

0.81

1.2

1.0

0.2

3.5

u/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

410

3807

1.08

0.81

3.3

3.0

0.7

0.19

390

3651

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

589

1.21

0.81

1.6

1.5

17.8

21.3

u/ml

0.40

116

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

239

2634

0.91

0.81

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

275

2510

1.10

0.81

2.4

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

681

1.19

0.81

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.57

0.81

1.1

0.0

0.4

u/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

124

1080

1.15

0.80

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

128

1119

1.15

0.79

1.6

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.3

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.78

0.0

1.0

—

423.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

295

1.29

0.78

2.5

2.8

26.9

28.1

umol/l

0.28

219

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

795

1.17

0.78

1.6

1.3

1.6

1.5

nmol/l

0.47

713

(3000330) Specific gravity of Urine by Test strip

461

4311

1.07

0.77

3.2

3.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

162

1442

1.13

0.77

1.8

1.7

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.76

0.0

1.1

—

(4146454)

108

937

1.15

0.75

2.8

2.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

752

1.17

0.75

2.2

1.9

0.4

1.4

g/24h

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.74

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

154

1371

1.13

0.74

2.7

2.6

60293.6

2417.8

u/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

115

1005

1.15

0.73

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

210

1.33

0.73

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

108

1.48

0.73

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

144

1278

1.13

0.73

1.1

120.2

117.2

0.58

131

1150

(3017569) Oxygen content in Arterial blood

424

0.78

0.72

2.8

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

209

1896

1.10

0.72

1.5

—

(3001556) Androgen free Index in Serum or Plasma

1.67

0.72

1.6

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

452

4239

1.07

0.71

1.8

1.7

—

(4281824)

1064

0.86

0.71

1.2

—

(3003694) ABO and Rh group [Type] in Blood

2334

23924

0.97

0.70

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

729

1.17

0.70

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

729

1.17

0.70

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

729

1.17

0.70

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

133

1496

0.89

0.69

3.5

3.0

0.8

nmol/l

0.13

102

1152

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.68

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

473

1.21

0.68

1.5

1.4

1.2

1.3

nmol/l

0.23

370

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.64

0.68

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

284

1.27

0.67

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.54

0.66

1.2

1.1

13.8

8.6

mg/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

119

1.43

0.66

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

157

1411

1.11

0.66

1.7

—

(40760410) HLA-B [Type] by High resolution

1.79

0.66

1.0

—

(40760409) HLA-A [Type] by High resolution

1.79

0.66

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.79

0.66

1.0

—

(40763590) HLA-DQ beta [Type]

1.79

0.66

1.0

—

(3027874) Urate [Moles/volume] in Urine

1.79

0.66

1.0

1.1

2.1

1.6

mmol/l

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

145

1298

1.12

0.66

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

810

1.15

0.65

1.4

176731.0

107215.6

e6/l

0.42

550

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

367

1.23

0.65

1.2

1.1

1605.4

1487.5

miu/ml

0.26

367

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

548

0.82

0.64

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

775

0.85

0.64

2.4

3.0

17.2

51.7

mg/l

1.95

561

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

986

9485

1.04

0.64

3.5

4.2

10.7

25.4

ug/l

3.13

764

7709

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

514

1.19

0.64

1.1

1.2

1.0

1.1

ratio

1.15

179

(3000012) Reticulocyte production index

459

1.20

0.63

1.9

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

450

1.20

0.63

1.2

1.1

24.5

28.7

u/l

0.19

334

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

207

1.31

0.63

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

432

1.20

0.63

1.4

1.5

4.8

3.9

—

100

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.49

0.63

1.0

—

(3004451) EKG impression Narrative

424

1.20

0.62

1.2

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

109

964

1.13

0.62

1.1

92.8

96.3

0.89

904

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

527

4997

1.06

0.61

1.5

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.67

0.61

1.2

1.4

1.3

1.4

—

(3013862) HLA-DP [Type]

1.67

0.61

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

402

0.80

0.61

2.4

3.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.60

0.61

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

196

1793

1.09

0.61

2.3

2.5

17.0

16.2

2.00

106

918

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

244

1.27

0.61

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

253

1.27

0.60

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.4

—

37.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

221

0.72

0.60

1.2

645.3

356.5

ug/l

—

126

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

12454.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

556

1.17

0.58

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

114

1.40

0.58

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.56

0.58

1.5

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

300

1.23

0.58

1.6

1.4

14.7

15.9

pmol/l

0.55

257

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

437

1.19

0.57

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

173

0.69

0.57

1.3

—

(3004775) Volume in Urine collected for unspecified duration

701

0.86

0.57

2.3

635.0

660.5

0.19

479

(3011325) HIV 1+2 Ab [Presence] in Serum

1.67

0.56

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

438

1.19

0.56

1.9

2.1

96.4

184.4

ug/min

—

106

(3032057) Clostridioides difficile [Presence] in Stool

184

0.71

0.56

2.0

1.9

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.43

0.56

1.0

1.2

4.4

6.3

mmol/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.45

0.55

1.2

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

240

0.75

0.55

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

357

1.21

0.55

2.3

2.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

530

5049

1.05

0.54

3.6

3.5

131.8

129.2

g/l

2.11

517

4928

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1059

0.89

0.54

2.2

1.7

—

(3047189) Immunofixation for 24 hour Urine

431

1.18

0.54

1.5

1.9

—

(3028717) Thiamine [Mass/volume] in Blood

1.41

0.54

1.1

1.2

—

(3024263) Appearance of Synovial fluid

459

1.18

0.54

1.4

1.7

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

213

1.27

0.53

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

213

1.27

0.53

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

213

1.27

0.53

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

213

1.27

0.53

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

258

2766

0.93

0.53

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

702

1.14

0.53

1.3

1.4

2.5

4.9

ug/l

1.79

589

(3006922) Hepatitis E virus Ab [Presence] in Serum

599

1.15

0.53

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

142

1290

1.10

0.53

1.5

1.4

—

(3019174) dRVVT (LA screen)

1.49

0.53

1.1

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

142

1291

1.10

0.52

1.5

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

451

1.18

0.52

1.2

1.1

76.4

89.3

u/l

1.14

344

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

554

1.16

0.52

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.61

0.52

1.5

1.3

64.0

74.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

152

1.32

0.52

1.4

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

152

1.32

0.52

1.1

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

212

1965

1.08

0.51

1.4

102.5

175.3

pmol/l

2.77

206

1916

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

576

0.85

0.51

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

141

1284

1.10

0.51

1.5

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.46

0.50

1.0

0.0

3.5

u/ml

—

(3016038) Potassium [Moles/volume] in Urine

556

1.15

0.50

1.1

38.2

35.2

mmol/l

0.43

472

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

412

0.82

0.50

1.6

1.5

7.5

7.9

mmol/l

0.63

245

(3006462) Nitrate [Presence] in Urine

389

1.18

0.50

4.5

3.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

547

1.15

0.50

1.3

1.4

—

(3036603) Volume of Urine

622

1.14

0.49

1.4

1.7

1903.7

1967.9

0.16

142

(3042517) Benzodiazepines panel - Urine

1.49

0.49

1.2

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

538

1.15

0.49

1.3

1.4

—

(4015189)

216

1.25

0.49

2.6

2.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.48

1.1

—

(40758292) HTLV I+II Ab panel - Serum

145

1.31

0.48

1.5

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

335

1.19

0.48

2.6

2.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

119

1.35

0.48

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

103

927

1.11

0.48

1.7

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

181

1.27

0.47

1.7

1.6

—

(44806071)

120

1.33

0.46

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

908

0.89

0.46

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

129

1.32

0.45

1.8

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

255

1.22

0.45

2.3

1.9

7.9

9.5

mg/l

0.89

208

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

254

2386

1.07

0.45

1.2

1.3

—

(40762814) Titanium [Mass/volume] in Blood

147

1.29

0.45

2.6

2.3

2.5

3.6

ug/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

675

1.13

0.45

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

282

2660

1.06

0.44

3.6

3.2

3.4

3.0

ratio

0.12

197

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

140

1287

1.09

0.44

1.5

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

130

1.31

0.43

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

284

1.20

0.43

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.61

0.43

1.2

1.4

492.4

624.4

nmol/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.56

0.42

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.56

0.42

1.0

0.0

0.2

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

251

0.80

0.42

1.8

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

349

3320

1.05

0.42

3.4

3.6

269.8

2041.6

u/ml

1.37

299

2844

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.41

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.35

0.41

1.0

1.7

6.2

7.4

mmol/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

305

0.82

0.41

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

249

1.21

0.41

1.1

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.41

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

337

0.83

0.41

1.3

1.5

—

(4211845)

426

1.15

0.40

4.4

3.2

—

(3020891) Body temperature

353

3364

1.05

0.40

5.1

4.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

123

1.30

0.40

1.3

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.33

0.40

1.0

1.3

—

13.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

250

1.20

0.40

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.40

0.0

1.2

—

2348.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

352

1.17

0.40

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

352

1.17

0.40

2.1

2.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.34

0.39

4.7

2.8

0.5

0.6

u/field

0.37

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

292

0.82

0.39

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

353

1.16

0.39

2.1

2.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.36

0.38

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

159

0.75

0.38

1.9

1.2

mmol/l

0.64

154

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

288

2736

1.05

0.38

3.8

3.3

29.8

45.3

mg/l

2.10

230

2234

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

373

1.15

0.37

2.7

2.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.35

0.37

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.30

0.37

1.0

1.1

12.2

13.4

u/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

225

1.20

0.37

2.0

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

1.39

0.36

1.1

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

116

0.69

0.36

5.0

3.4

43.5

39.6

umol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

696

1.11

0.36

1.2

1.3

11.8

11.7

mmol/l

0.00

203

(3010375) cycloSPORINE [Mass/volume] in Blood

385

1.14

0.35

33.8

26.3

108.4

112.2

ug/l

0.15

315

(40768446) Kidney Pathology biopsy report

352

0.85

0.35

1.5

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

329

1.16

0.34

4.1

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

350

3354

1.05

0.34

2.1

2.0

1.3

2.2

ug/l

1.74

302

2995

(3034860) Kappa light chains.free [Mass/volume] in Serum

287

2738

1.05

0.34

3.8

3.3

59.8

73.4

mg/l

0.23

231

2237

(1761868) Lipid panel - Serum or Plasma

3061

30975

0.98

0.34

2.9

2.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

182

1.21

0.33

1.1

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

219

1.19

0.33

1.1

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.67

0.32

1.0

1.3

—

551.7

—

(40768795) Lymph node Pathology biopsy report

101

932

1.08

0.32

1.4

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.35

0.32

1.7

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

110

1020

1.08

0.32

1.3

1.2

61.4

63.1

u/l

0.07

687

(3034426) Prothrombin time (PT)

323

1.15

0.31

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.73

0.30

1.1

1.0

—

(4198724)

315

0.86

0.30

10.5

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

147

1382

1.06

0.30

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.33

0.30

1.9

2.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

102

1.27

0.30

2.5

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

217

2066

1.05

0.29

2.5

3.1

24.6

24.9

mmol/l

0.76

184

1808

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

130

0.77

0.29

7.3

12.0

6.1

5.5

mmol/l

—

130

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

919

8988

1.02

0.29

3.0

3.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

157

1482

1.06

0.29

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

587

0.90

0.29

1.3

1.4

1.5

g/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

411

1.12

0.28

1.2

1.1

41.5

15.5

u/ml

—

(40757373) Influenza virus identified in Isolate

167

1.20

0.28

1.9

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

148

1397

1.06

0.28

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

661

1.09

0.28

2.4

2.0

2.4

1.9

u/field

0.27

273

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.27

0.27

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

365

1.12

0.27

2.3

2.2

52.3

54.6

umol/l

0.19

303

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

140

1.21

0.27

2.6

3.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

614

1.09

0.27

1.3

1.2

77.5

88.9

u/l

0.61

525

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.21

0.26

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

193

0.83

0.26

1.5

1.8

38.2

2.3

ug/l

—

101

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

884

0.93

0.26

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

712

1.08

0.26

1.8

3.3

3.9

mg/l

0.64

672

(3041918) Cholesterol [Moles/volume] in Pleural fluid

160

0.81

0.26

1.2

1.8

1.7

mmol/l

—

(3042631) Mycobacterium sp identified in Specimen

122

1149

1.06

0.25

3.5

2.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

202

0.84

0.24

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

287

0.87

0.24

4.8

5.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

168

1600

1.05

0.24

1.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

734

1.08

0.24

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.17

0.24

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.17

0.24

1.8

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

178

1863

0.95

0.23

2.6

2.8

30.4

34.7

umol/l

2.01

155

1588

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

233

0.86

0.23

8.5

8.3

—

(3002619) Bacteria identified in Specimen by Culture

180

1.17

0.23

1.1

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.32

0.23

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

113

1067

1.06

0.23

1.6

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

153

1458

1.05

0.22

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

776

7608

1.02

0.22

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

689

1.07

0.22

1.4

1.5

1.2

1.4

promille

0.30

528

(3037556) Urate [Mass/volume] in Serum or Plasma

257

1.13

0.22

1.6

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.19

0.21

1.2

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.21

0.0

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.16

0.21

1.4

314.0

141.2

ug/g

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.21

9.0

10.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.16

0.21

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.20

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

738

7244

1.02

0.20

4.0

3.8

1.2

mmol/l

0.07

634

6345

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

422

1.09

0.20

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

422

1.09

0.20

1.4

1.5

—

(4035726)

838

8238

1.02

0.20

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

386

0.91

0.20

34.2

34.9

7.4

7.3

ug/l

0.08

351

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

461

1.09

0.19

1.4

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

288

1.11

0.19

1.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

127

1.18

0.19

1.1

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

186

1790

1.04

0.19

2.5

2.9

8.7

8.1

kpa

4.72

166

1661

(1617658) Protocol used for examination of sentinel lymph nodes

685

0.93

0.19

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

254

2460

1.03

0.19

1.6

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.22

0.19

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

234

2264

1.03

0.19

3.6

3.0

1.4

1.5

mg/l

2.41

214

2085

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

901

1.05

0.18

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

386

1.09

0.18

1.0

1.1

98.1

94.7

0.38

303

(3020650) Glucose [Presence] in Urine

227

0.88

0.18

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

454

1.08

0.18

1.9

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

454

1.08

0.18

1.9

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

454

1.08

0.18

1.9

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

464

1.08

0.17

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

174

1804

0.96

0.17

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

455

1.08

0.17

1.9

2.0

—

(3020491) Glucose [Moles/volume] in Blood

631

1.06

0.16

1.6

2.0

6.9

6.8

mmol/l

0.05

439

(3044927) Protein electrophoresis panel - Urine

836

1.05

0.16

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

401

3923

1.02

0.16

3.0

3.5

25.4

25.3

mmol/l

0.36

383

3809

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.14

0.16

1.0

—

(3005033) Fetal Nuchal fold Thickness US

111

1062

1.05

0.16

1.6

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

593

1.06

0.16

2.0

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

187

1.12

0.15

2.6

2.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.78

0.15

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

526

1.06

0.15

1.4

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.14

0.15

3.3

2.5

—

(3051101) Glucose [Moles/volume] in Cord blood

140

0.86

0.15

4.9

6.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.11

0.15

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.10

0.15

1.9

2.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

167

1725

0.97

0.14

1.5

1.8

0.8

nmol/l

0.46

145

1453

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

217

1.11

0.14

1.4

1.3

—

(4212803)

0.79

0.14

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

112

1.16

0.14

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

542

0.94

0.14

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.83

0.13

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

151

1.13

0.13

1.1

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

200

2054

0.97

0.13

4.2

3.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

117

0.85

0.13

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

458

0.94

0.12

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

219

1.10

0.12

1.5

1.3

31.3

38.6

0.50

148

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

171

1.11

0.12

1.3

1.5

84.6

125.9

ng/l

1.92

171

(3020393) Adenovirus Ag [Presence] in Stool

1.18

0.12

1.4

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

198

1930

1.03

0.12

1.9

2.2

132.3

129.1

g/l

1.06

134

1352

(3006442) Creatine [Moles/volume] in Serum or Plasma

580

1.05

0.12

1.3

1.6

62.4

70.2

umol/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

114

1101

1.04

0.12

1.6

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

600

1.05

0.12

1.3

1.2

18.4

23.6

u/l

0.60

501

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

376

1.06

0.11

1.8

2.0

83.4

125.3

umol/l

0.58

194

(3019977) pH of Arterial blood

486

0.95

0.11

2.8

2.7

7.4

0.36

165

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

118

1217

0.97

0.11

6.9

6.6

11.9

11.6

mg/l

0.36

112

1114

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.15

0.10

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

204

2084

0.98

0.10

3.9

—

(3021901) Oxygen saturation in Capillary blood

153

1492

1.03

0.10

2.4

2.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

361

0.94

0.09

1.5

1.4

—

1299262.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

762

1.04

0.09

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.09

0.09

1.2

1.0

—

27.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

242

1.07

0.09

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.06

0.09

1.2

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.06

0.09

1.2

1.6

—

(3051339) Copper [Moles/volume] in Blood

1.04

0.09

1.0

1.1

15.5

16.6

umol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

168

1643

1.02

0.09

3.3

3.2

7.3

7.6

mmol/l

0.93

163

1608

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

150

1466

1.02

0.09

1.1

—

(3016750) Collection duration of Urine

508

1.04

0.08

2.2

495.3

496.8

min

0.05

379

(3009466) Valproate [Moles/volume] in Serum or Plasma

121

1241

0.97

0.08

4.7

4.9

344.9

364.1

umol/l

0.76

101

1064

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

115

1180

0.97

0.08

1.2

1.3

7.1

7.3

mmol/l

0.51

878

(3012501) Base excess in Blood by calculation

200

1964

1.02

0.08

3.5

4.0

2.0

2.6

mmol/l

2.89

142

1377

(1616796) Gas panel - Central venous blood

192

1885

1.02

0.08

2.9

3.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.12

0.07

1.2

—

(3003129) Base excess in Capillary blood by calculation

215

1.07

0.07

1.4

1.9

1.0

0.7

mmol/l

0.25

202

(3043409) Potassium [Moles/volume] in Arterial blood

252

2557

0.99

0.07

4.6

4.5

3.8

3.9

mmol/l

0.65

246

2404

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

108

1.11

0.07

1.1

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

284

1.06

0.07

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

305

3011

1.01

0.07

3.2

0.4

u/ml

0.17

169

1698

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

360

3642

0.99

0.07

3.9

4.0

48.8

48.6

0.04

354

3597

(3050794) Legionella sp Ab [Presence] in Serum

0.85

0.07

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

956

1.03

0.07

1.9

2.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

204

0.93

0.07

8.6

8.3

—

(3052592) Norovirus Ag [Presence] in Stool

157

1.08

0.07

1.5

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

171

1740

0.98

0.07

3.2

3.1

1.5

1.6

mmol/l

1.97

166

1695

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

163

0.92

0.07

9.1

7.2

—

(3014891) Appearance of Pleural fluid

104

0.87

0.06

2.2

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

246

1.06

0.06

1.3

55.4

53.6

0.08

205

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

649

0.97

0.06

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

175

1724

1.02

0.06

1.9

1.6

—

(3010421) pH of Blood

232

2292

1.01

0.05

3.4

4.0

7.4

0.14

196

1928

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

129

1268

1.02

0.05

3.3

2.6

5566.3

1111.6

u/ml

0.41

123

1221

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

455

0.97

0.05

2.7

1.9

1.8

2.8

u/field

0.71

320

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

828

0.98

0.05

1.2

—

(3024932) HLA-DR beta [Type]

279

1.04

0.04

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

129

0.93

0.03

1.1

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

139

0.94

0.03

4.8

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

139

0.94

0.03

9.7

5.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

667

1.02

0.03

1.1

1.0

287.3

289.2

mg/l

0.07

600

(21494890) Protein electrophoresis panel - 24 hour Urine

916

1.02

0.03

2.0

2.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

108

1094

0.99

0.03

2.6

2.1

32.8

0.00

108

1085

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

121

1197

1.01

0.02

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

309

0.97

0.02

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

869

1.01

0.02

2.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

441

1.02

0.02

5.0

5.4

55.5

8314.0

u/ml

—

(44806420)

223

1.03

0.01

2.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

114

1.05

0.00

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

116

0.95

0.00

9.1

8.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

176

0.97

0.00

1.0

—

(3024471) HLA-A [Type]

284

1.02

0.00

1.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

777

7762

1.00

0.00

7.1

7.6

9.1

9.7

mmol/l

2.33

739

7404

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

127

1.02

0.00

4.5

4.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

143

0.98

0.00

2.1

3.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

603

0.99

0.00

1.7

1.5

8.3

5.6

u/l

0.20

298

(40762365) Oxygen content in Arterial blood by calculation

161

0.99

0.00

2.8

2.6

14.8

14.9

ml/dl

0.08

151

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

211

1.00

0.00

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

149

1.01

0.00

1.5

2.0

18.8

16.9

umol/l

0.30

149

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

36.9

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

2.7

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

300.8

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

7.8

—

(3027020) Pear IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

45.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.97

0.00

1.3

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.95

0.00

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.00

0.00

1.9

2.1

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.85

0.00

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.89

0.00

2.1

1.7

46.6

39.8

umol/l

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.00

0.00

1.3

19.3

1731.6

u/l

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.88

0.00

1.4

4.2

13.7

42.9

g/mol

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.3

—

4.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.98

0.00

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.1

—

69.1

—

(3025315) Body weight

0.99

0.00

4.3

4.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.93

0.00

1.6

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.00

0.00

2.6

5.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.96

0.00

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_TINNITUS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_TINNITUS	0.766 [0.69, 0.84]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 2297 out of 27203 females with H8_TINNITUS died.

Males

Parameter	HR [95% CI]	p-value
H8_TINNITUS	0.731 [0.67, 0.8]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 2500 out of 24807 males with H8_TINNITUS died.

Mortality risk

Mortality risk for people of age

years, who have H8_TINNITUS.

N-year risk	Females	Males
1	0.067%	0.142%
5	0.368%	0.869%
10	0.959%	2.177%
15	1.757%	4.097%
20	3.146%	7.19%

Relationships between endpoints

↥

Index endpoint: H8_TINNITUS – Tinnitus

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Tinnitus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints